]> C62.0 Undescended testis C62.1 Descended testis C62.9 Testis, NOS Note 1: Instructions for coding pre- or post-orchiectomy tumor marker values were ambiguous for CS version 1 and there was variation in data collection by registrars. Furthermore, AJCC 7th Edition clarified that S value stage group IS is to be calculated based on the persistence of elevated serum tumor markers after surgery. As a consequence, there is uncertainly about the reliability of the data for the S parameter in data collected with CS version 1. The data elements and codes have been modified in CS version 2 to calculate the S value correctly. Any analysis of testis staging over time relying on the tumor marker data collected in CS version 1 might require review of medical records to verify the appropriate preoperative tumor marker values and the presence of persistent tumor markers post-orchiectomy. Note 2: CS version 2 corrects some version 1 errors in the calculation of the N category. For this reason, analysis of data originally collected in version 1 may show a different distribution of N categories and stage groups once the version 2 algorithm is run to re-derive AJCC 6th edition staging. Note 3: For cases collected in CSv1, the T category is derived using the Extension Orchiectomy Table CSv1, the S value is derived using the Serum Marker S Value Table CSv1, and the AJCC 6th Edition stage is derived using the AJCC TNM 6 Stage CSv1 table. Note 4: For cases collected in CSv2, the T category is derived using the Extension Orchiectomy LVI Table CSv2, the S value is derived using the Preorchiectomy Serum Marker S Value Table CSv2, and the AJCC 6th and 7th Edition stages are derived using the AJCC TNM 6 Stage table and AJCC TNM 7 Stage table. Note 5: Laterality must be coded for this site. &generalsize; CS Extension Note 1: According to AJCC, "Except for pTis and pT4, extent of primary tumor for TNM is classified by radical orchiectomy. TX is used for other categories in the absence of radical orchiectomy." For Collaborative Stage, this means that the categories of T1, T2, and T3 are derived only when CS Site Specific Factor 4 indicates that a radical orchiectomy is performed. Note 2: Involvement of para-testicular (hilar/mediastinal) soft tissues does not alter the extension code. Code the extension based on other criteria documented in the patient record. Note 3: Use code 300 (Localized, NOS) only when no further information is available to assign code 160, 200, 310, 320, or 330. Note 4: Use codes 320, 330, 550, or 810 if the only information regarding tumor extension is the physician's statement of the T category. Code Description TNM 7 Map TNM 6 Map SS77 Map SS2000 Map 000 Tis Tis IS IS 100 ERROR * L L 150 ERROR * L L 160 ^ * L L 200 ^ * L L 300 Localized, NOS ^ * L L 310 Tunica, NOS ^ * L L 320 Stated as T1 with no other information on extension ^ * L L 330 Stated as T2 with no other information on extension ^ * L L 400 ERROR * RE RE 450 ERROR * RE RE 460 ^ * RE RE 470 ^ * RE RE 500 ^ * RE RE 550 ^ * RE RE 600 T4 T4 RE RE 700 T4 T4 D D 750 Penis T4 T4 D D 800 Further contiguous extension T4 T4 D D 810 Stated as T4 with no other information on extension T4 T4 RE RE 950 No evidence of primary tumor T0 T0 U U 999 TX TX U U ^ For CS Extension codes 160-330 and 460-550 ONLY, the T category for AJCC 7 staging is assigned based on the values of CS Extension, CS Site-Specific Factor 4, Radical Orchiectomy Performed, and Lymph-vascular Invasion, as shown in the Extension Orchiectomy LVI AJCC 7 Table. * For cases coded under CSv1 (CS Version Input Original less than 020000) and Year of Diagnosis less than 2010 with CS Extension codes 100-550, the T category for AJCC 6 staging is assigned based on the values of CS Extension, Lymph-vascular Invasion, and CS Site-Specific Factor 4, Radical Orchiectomy Performed, as shown in the Extension Orchiectomy LVI AJCC 6 Table CSv1. For cases coded under CSv2 (CS Version Input Original greater than 020000) or Year of Diagnosis greater than 2009 with CS Extension codes 100-550, the T category for AJCC 6 staging is assigned based on the values of CS Extension, CS Site-Specific Factor 4, Radical Orchiectomy Performed, and Lymph-vascular Invasion, as shown in the Extension Orchiectomy LVI AJCC 6 Table CSv2. &generalcstsexteval; CS Lymph Nodes Note 1: Regional nodes in codes 100-300 include contralateral and bilateral nodes. Note 2: Involvement of inguinal, pelvic, or external iliac lymph nodes (codes 300 and 400) WITHOUT previous scrotal or inguinal surgery prior to presentation of the testis tumor is coded in CS Mets at DX, as distant lymph node involvement. Code Description TNM 7 Map TNM 6 Map SS77 Map SS2000 Map 000 No regional lymph node involvement N0 N0 NONE NONE 100 ^ * RN RN 200 ^ * D RN 300 ^ * RN RN 350 ^ * D RN 400 ^ * D D 500 Regional lymph node(s), NOS ^ * RN RN 510 Stated as N1 with no other information on regional lymph nodes N1 N1 RN RN 520 Stated as N2 with no other information on regional lymph nodes N2 N2 RN RN 530 Stated as N3 with no other information on regional lymph nodes N3 N3 RN RN 800 Lymph nodes, NOS N1 N1 RN RN 999 NX NX U U ^ For CS Lymph Nodes codes 100-500 ONLY, the N category for AJCC 7 staging is assigned based on the values of CS Site-Specific Factor 5, Size of Metastasis in Lymph Nodes, Regional Nodes Positive, and CS Lymph Nodes Eval. If the CS Lymph Nodes Eval code is 2 (p), 3 (p), 6 (yp), or 8 (a), the N category is determined by using the Lymph Nodes Pathologic Evaluation Table. If the CS Lymph Nodes Eval code is 0 (c), 1 (c), 5 (c), or 9 (c), the N category is determined by using the Lymph Nodes Clinical Evaluation Table. If the CS Lymph Nodes Eval field is not coded, the N category is determined by using the Lymph Nodes Positive Eval Blank Table. * For CS Lymph Nodes codes 100-500 ONLY, the N category for AJCC 6 staging is assigned based on the values of CS Site Specific Factor 5, Size of Metastasis in Lymph Nodes, Regional Nodes Positive and CS Lymph Nodes Eval. If the CS Lymph Nodes Eval code is 2 (p), 3 (p), 6 (yp), or 8 (a), the N category is determined by using the Lymph Nodes Pathologic Evaluation Table. If the CS Lymph Nodes Eval code is 0 (c), 1 (c), 5 (c), or 9 (c), the N category is determined by using the Lymph Nodes Clinical Evaluation Table. If the CS Lymph Nodes Eval field is not coded, the N category is determined by using the Lymph Nodes Positive Eval Blank Table. &generalregnodeseval; &commonreglnpos_active; &generalreglnexam; CS Mets at DX Note: Involvement of inguinal, pelvic, or external iliac lymph nodes (codes 11 and 12) with previous scrotal or inguinal surgery prior to presentation of the testis tumor is coded in CS Lymph Nodes as regional node involvement and not in CS Mets at DX. Code Description TNM 7 Map TNM 6 Map SS77 Map SS2000 Map 00 No distant metastasis M0 M0 NONE NONE 11 M1a M1a RN RN 12 M1a M1a D D 13 M1a M1a D D 20 Distant metastasis to lung M1a M1a D D 25 M1a M1a D D 30 Stated as M1a with no other information on metastasis M1a M1a D D 40 M1b M1b D D 45 ERROR ERROR ERROR ERROR 60 M1NOS M1NOS D D 99 M0 MX U U &commonmetsevalprostate; CS Site-Specific Factor 1 OBSOLETE - Alpha Fetoprotein (AFP) Note: This CS Site-Specific Factor is obsolete beginning with CS Version 2 (codes and descriptions). Old data are retained, but new cases are not coded with this Site-Specific Factor. Use code 988 for this field. Code Description 000 020 040 050 060 080 988 Not applicable: Information not collected for this schema 999 CS Site-Specific Factor 2 OBSOLETE - Human Chorionic Gonadotropin (hCG) Note: This CS Site-Specific Factor is obsolete beginning with CS Version 2 (codes and descriptions). Old data are retained, but new cases are not coded with this Factor. Use code 988 for this field. Code Description 000 020 040 050 060 080 988 Not applicable: Information not collected for this schema 999 CS Site-Specific Factor 3 OBSOLETE - Lactate Dehydrogenase (LDH) Note 1: This CS Site-Specific Factor is obsolete beginning with CS Version 2 (codes and descriptions). Old data are retained, but new cases are not coded with this Factor. Use code 988 for this field. Code Description 000 020 040 050 060 080 988 Not applicable: Information not collected for this schema 999 CS Site-Specific Factor 4 Radical Orchiectomy Performed Code Description 000 Radical orchiectomy not performed 001 010 Radical orchiectomy performed 988 999 Unknown if radical orchiectomy performed CS Site-Specific Factor 5 Size of Metastasis in Lymph Nodes Note 1: If the only information on the size of the metastatic lymph node mass is the physician's assignment of the N category, assign code 010 for N1, 020 for N2, or 030 for N3. Note 2: If extranodal extension is not described on the pathology report or pathologic assessment of regional lymph nodes is not performed, assume extranodal extension is not present. Note 3: Do not code the size of any node coded in CS Mets at DX. Code Description 000 No lymph node metastasis 001 002 003 010 020 030 988 998 999 CS Site-Specific Factor 6 Pre-Orchiectomy Alpha Fetoprotein (AFP) Lab Value Note 1: Record the value of the alpha fetoprotein (AFP) test as documented in the patient record prior to orchiectomy and other treatment. Note 2: Use the same laboratory test to record values for CS Site-Specific Factors 6 and 7. Note 3: Record a pretreatment AFP of 20 nanograms/milliliter (ng/ml) as 002; record a pretreatment AFP of 11,000 ng/ml as 200. Note 4: Code 000 is reserved for exactly 0.0 ng/ml (no measurable amount of AFP). Do not round tiny values down to 0.0 ng/ml; any measured value less than or equal to 0.1 ng/ml should be coded 001. For values greater than 001 ng/ml, round values to the nearest ng/ml. Note 5: A lab value expressed in micrograms/liter (ug/l) is equivalent to the same value expressed in ng/ml. Note 6: If the pre-orchiectomy AFP test is done but the actual value is not stated, use code 997. Note 7: For rare cases that are treated prior to orchiectomy, use code 995 in this field and record the initial AFP lab value in CS Site-Specific Factor 12. Note 8: For rare cases that an orchiectomy is not performed, use code 996 in this field and record the initial AFP lab value in CS Site-Specific Factor 12. Code Description 000 0 nanograms/milliliter (ng/ml) 001 1 - 19 ng/ml 002 20 - 29 ng/ml 003 30 - 39 ng/ml 004 40 - 49 ng/ml 005 50 - 59 ng/ml 006 60 - 69 ng/ml 007 70 - 79 ng/ml 008 80 - 89 ng/ml 009 90 - 99 ng/ml 010 100 - 199 ng/ml 020 200 - 299 ng/ml 030 300 - 399 ng/ml 040 400 - 499 ng/ml 050 500 - 599 ng/ml 060 600 - 699 ng/ml 070 700 - 799 ng/ml 080 800 - 899 ng/ml 090 900 - 999 ng/ml 100 1000 - 1999 ng/ml 120 2000 - 2999 ng/ml 130 3000 - 3999 ng/ml 140 4000 - 4999 ng/ml 150 5000 - 5999 ng/ml 160 6000 - 6999 ng/ml 170 7000 - 7999 ng/ml 180 8000 - 8999 ng/ml 190 9000 - 9999 ng/ml 200 Greater than or equal to 10, 000 ng/ml 888 988 995 Pretreated case, initial alpha fetoprotein (AFP) lab value recorded in CS Site-Specific Factor 12 996 No orchiectomy performed, initial AFP lab value recorded in CS Site-Specific Factor 12 997 Test ordered, results not in chart 998 Test not done (test not ordered and not performed) 999 CS Site-Specific Factor 7 Pre-Orchiectomy Alpha Fetoprotein (AFP) Range Note 1: Record the range of the alpha fetoprotein (AFP) test as documented in the patient record prior to orchiectomy and other treatment. Note 2: Use the same laboratory test to record values for CS Site-Specific Factors 6 and 7. Note 3: A lab value expressed in micrograms/liter (ug/L) is equivalent to the same value expressed in nanograms/milliliter (ng/ml). Note 4: If the pre-orchiectomy AFP test is unavailable but a physician's statement of the result is documented, use codes 991-993. Note 5: For rare cases that are treated prior to orchiectomy, use code 995 in this field and record the initial AFP range in CS Site-Specific Factor 13. Note 6: For rare cases that an orchiectomy is not performed, use code 996 in this field and record the initial AFP range in CS Site-Specific Factor 13. Code Description 000 Within normal limits (S0) 010 Range 1 (S1) above normal and less than 1,000 nanograms/milliliter (ng/ml) 020 Range 2 (S2) 1,000 -10,000 ng/ml 030 Range 3 (S3) greater than 10,000 ng/ml 988 991 Pre-orchiectomy alpha fetoprotein (AFP) stated to be elevated 992 Pre-orchiectomy AFP unknown but preorchiectomy serum tumor markers NOS stated to be normal 993 Pre-orchiectomy AFP unknown but preorchiectomy serum tumor markers NOS stated to be elevated 995 Pretreated case, initial AFP range recorded in CS Site-Specific Factor 13 996 No orchiectomy performed, initial AFP range recorded in CS Site-Specific Factor 13 997 Test ordered, results not in chart 998 Test not done (test not ordered and not performed) 999 CS Site-Specific Factor 8 Pre-Orchiectomy Human Chorionic Gonadotropin (hCG) Lab Value Note 1: Record the value of the human chorionic gonadotropin (hCG) test as documented in the patient record prior to orchiectomy and other treatment. Note 2: Use the same laboratory test to record values for CS Site-Specific Factors 8 and 9. Note 3: Record a pretreatment hCG of 20 milli-International Units/milliliter (mIU/ml) as 002; record a pretreatment hCG of 11, 000 mIU/ml as 200. Note 4: Code 000 is reserved for exactly 0.0 mIU/ml (no measurable amount of hCG). Do not round tiny values down to 0.0 mIU/ml; any measured value less than or equal to 0.1 mIU/ml should be coded 001. For values greater than 001 mIU/ml, round values to the nearest mIU/ml. Note 5: A lab value expressed in International Units/liter (IU/L) is equivalent to the same value expressed in milli-International Units/milliliter (mIU/ml). Note 6: If the preorchiectomy hCG test is done but the actual value is not stated, use code 997. Note 7: For rare cases that are treated prior to orchiectomy, use code 995 in this field and record the initial hCG lab value in CS Site-Specific Factor 14. Note 8: For rare cases that an orchiectomy is not performed, use code 996 in this field and record the initial hCG lab value in CS Site-Specific Factor 14. Code Description 000 0 milli-International Units/milliliter (mIU/ml) 001 1 - 19 mIU/ml 002 20 - 29 mIU/ml 003 30 - 39 mIU/ml 004 40 - 49 mIU/ml 005 50 - 59 mIU/ml 006 60 - 69 mIU/ml 007 70 - 79 mIU/ml 008 80 - 89 mIU/ml 009 90 - 99 mIU/ml 010 100 - 199 mIU/ml 020 200 - 299 mIU/ml 030 300 - 399 mIU/ml 040 400 - 499 mIU/ml 050 500 - 599 mIU/ml 060 600 - 699 mIU/ml 070 700 - 799 mIU/ml 080 800 - 899 mIU/ml 090 900 - 999 mIU/ml 100 1000 - 1999 mIU/ml 120 2000 - 2999 mIU/ml 130 3000 - 3999 mIU/ml 140 4000 - 4999 mIU/ml 150 5000 - 5999 mIU/ml 160 6000 - 6999 mIU/ml 170 7000 - 7999 mIU/ml 180 8000 - 8999 mIU/ml 190 9000 - 9999 mIU/ml 200 10, 000 - 19, 999 mIU/ml 220 20, 000 - 29, 999 mIU/ml 230 30, 000 - 39, 999 mIU/ml 240 40, 000 - 49, 999 mIU/ml 250 Greater than or equal to 50,000 mIU/ml 988 995 Pretreated case, initial human chorionic gonadotropin (hCG) lab value recorded in CS Site-Specific Factor 14 996 No orchiectomy performed, initial hCG lab value recorded in CS Site-Specific Factor 14 997 Test ordered, results not in chart 998 Test not done (test not ordered and not performed) 999 CS Site-Specific Factor 9 Pre-Orchiectomy Human Chorionic Gonadotropin (hCG) Range Note 1: Record the range of the human chorionic gonadotropin (hCG) test as documented in the patient record prior to orchiectomy and other treatment. Note 2: Use the same laboratory test to record values in CS Site-Specific Factors 8 and 9. Note 3: A lab value expressed in International Units/liter (IU/L) is equivalent to the same value expressed in milli-International Units/milliliter (mIU/ml). Note 4: If the pre-orchiectomy hCG test is unavailable but a physician's statement of the result is documented, use codes 991-993. Note 5: For rare cases that are treated prior to orchiectomy, use code 995 in this field and record the initial hCG range in CS Site-Specific Factor 15. Note 6: For rare cases that an orchiectomy is not performed, use code 996 in this field and record the initial hCG range in CS Site-Specific Factor 15. Code Description 000 Within normal limits (S0) 010 Range 1 (S1) above normal and less than 5,000 milli-International Units/milliliter (mIU/ml) 020 Range 2 (S2) 5,000 - 50,000 mIU/ml 030 Range 3 (S3) greater than 50,000 mIU/ml 988 991 Pre-orchiectomy human chorionic gonadotropin (hCG) stated to be elevated 992 Pre-orchiectomy hCG unknown but preorchiectomy serum tumor markers NOS stated to be normal 993 Pre-orchiectomy hCG unknown but preorchiectomy serum tumor markers NOS stated to be elevated 995 Pretreated case, initial hCG range recorded in CS Site-Specific Factor 15 996 No orchiectomy performed, initial hCG range recorded in CS Site-Specific Factor 15 997 Test ordered, results not in chart 998 Test not done (test not ordered and not performed 999 CS Site-Specific Factor 10 Pre-Orchiectomy Lactate Dehydrogenase (LDH) Range Note 1: Of the three tumor markers, lactate dehydrogenase (LDH) is the least specific for testicular cancer and is more of a determinant of bulky or disseminated disease. Although recommended to be tested, LDH may not be routinely performed, especially if the primary is localized. Note 2: Record the range of the LDH test as documented in the patient record prior to orchiectomy and other treatment. Note 3: If the pre-orchiectomy LDH test is unavailable but a physician's statement of the result is documented, use codes 991-993. Note 4: For rare cases that are treated prior to orchiectomy, use code 995 in this field and record the initial LDH range in CS Site-Specific Factor 16. Note 5: For rare cases that an orchiectomy is not performed, use code 996 in this field and record the initial LDH range in CS Site-Specific Factor 16. Code Description 000 Within normal limits (S0) 010 020 030 988 991 Pre-orchiectomy LDH stated to be elevated 992 Pre-orchiectomy LDH unknown but preorchiectomy serum tumor markers NOS stated to be normal 993 Pre-orchiectomy LDH unknown but preorchiectomy serum tumor markers NOS stated to be elevated 995 Pretreated case, initial LDH range recorded in CS Site-Specific Factor 16 996 No orchiectomy performed, initial LDH range recorded in CS Site-Specific Factor 16 997 Test ordered, results not in chart 998 Test not done (test not ordered and not performed) 999 CS Site-Specific Factor 11 OBSOLETE - Persistence of Elevated Serum Tumor Markers Note: This CS Site-Specific Factor is obsolete beginning with CS Version 0203 (codes, code descriptions, and notes). Old data are retained but the cases are reviewed and recoded in CS Site-Specific Factors 13, 15, and 16. Use code 988 for this field for all cases entered in version 0203. OBSOLETE V0203 Note: The persistence of elevated serum tumor markers is required to determine AJCC stage group IS. Record the presence or absence of persistent elevated serum tumor markers POSTORCHIECTOMY as stated by the physician in the patient record. Do not attempt to interpret the lab tests to determine the persistence of elevation. If the serum tumor markers were normal prior to orchiectomy, code 000. Code Description 000 010 988 999 CS Site-Specific Factor 12 Post-Orchiectomy Alpha Fetoprotein (AFP) Lab Value Note 1: Record the value of the alpha fetoprotein (AFP) test as documented in the patient record after orchiectomy and prior to further treatment. Note 2: Use the same laboratory test to record values for CS Site-Specific Factors 12 and 13. Note 3: Record a post-orchiectomy AFP of 20 nanograms/milliliter (ng/ml) as 002; record a post-orchiectomy AFP of 11,000 ng/ml as 200. Note 4: Code 000 is reserved for exactly 0.0 ng/ml (no measurable amount of AFP). Do not round tiny values down to 0.0 ng/ml; any measured value less than or equal to 0.1 ng/ml should be coded 001. For values greater than 001 ng/ml, round values to the nearest ng/ml. Note 5: A lab value expressed in micrograms/liter (ug/L) is equivalent to the same value expressed in ng/ml. Note 6: If the initial post-orchiectomy AFP test remains elevated, review the subsequent tests until normalization or plateau occurs and use that test to code this field. See Part I for further explanation of serum tumor marker half life. Note 7: If the post-orchiectomy AFP test is done but the actual value is not stated, use code 997. Note 8: For rare cases that are treated prior to orchiectomy or an orchiectomy is not performed, code the initial AFP lab value in this field and not in CS Site-Specific Factor 6. Code Description 000 0 nanograms/milliliter (ng/ml) 001 002 003 004 005 50 - 59 ng/ml 006 60 - 69 ng/ml 007 70 - 79 ng/ml 008 80 - 89 ng/ml 009 90 - 99 ng/ml 010 100 - 199 ng/ml 020 200 - 299 ng/ml 030 300 - 399 ng/ml 040 400 - 499 ng/ml 050 500 - 599 ng/ml 060 600 - 699 ng/ml 070 700 - 799 ng/ml 080 800 - 899 ng/ml 090 900 - 999 ng/ml 100 1000 - 1999 ng/ml 120 2000 - 2999 ng/ml 130 3000 - 3999 ng/ml 140 4000 - 4999 ng/ml 150 5000 - 5999 ng/ml 160 6000 - 6999 ng/ml 170 7000 - 7999 ng/ml 180 8000 - 8999 ng/ml 190 9000 - 9999 ng/ml 200 Greater than or equal to 10, 000 ng/ml 988 997 Test ordered, results not in chart 998 Test not done (test not ordered and not performed) 999 CS Site-Specific Factor 13 Post-Orchiectomy Alpha Fetoprotein (AFP) Range Note 1: Record the range of the alpha fetoprotein (AFP) test as documented in the patient record after orchiectomy and prior to further treatment. Note 2: Use the same laboratory test to record values for CS Site-Specific Factors 12 and 13. Note 3: A lab value expressed in micrograms/liter (ug/L) is equivalent to the same value expressed in nanograms/milliliter (ng/ml). Note 4: If the initial post-orchiectomy AFP test remains elevated, review the subsequent tests until normalization or plateau occurs and use that test to code this field. See Part I for further explanation of serum tumor marker half life. Note 5: If the post-orchiectomy AFP test is unknown but the preorchiectomy AFP test was normal, use code 990. Note 6: If the post-orchiectomy AFP test is unavailable but a physician's statement of the result is documented, use codes 991-993. Note 7: For rare cases that are treated prior to orchiectomy or an orchiectomy is not performed, code the initial AFP range in this field and not in CS Site-Specific Factor 7. Code Description 000 Within normal limits (S0) 010 020 030 988 990 Post-orchiectomy alpha fetoprotein (AFP) unknown but preorchiectomy AFP was normal 991 Post-orchiectomy AFP stated to be still elevated 992 Post-orchiectomy AFP unknown but post-orchiectomy serum tumor markers NOS stated to be normal 993 997 Test ordered, results not in chart 998 Test not done (test not ordered and not performed) 999 CS Site-Specific Factor 14 Post-Orchiectomy Human Chorionic Gonadotropin (hCG) Lab Value Note 1: Record the value of the human chorionic gonadotropin (hCG) test as documented in the patient record after orchiectomy and prior to further treatment. Note 2: Use the same laboratory test to record values for CS Site-Specific Factors 14 and 15. Note 3: Record a post-orchiectomy hCG of 20 milli-International Units (mIU/ml) as 002; record a post-orchiectomy hCG of 11, 000 mIU/ml as 200. Note 4: Code 000 is reserved for exactly 0.0 mIU/ml (no measurable amount of hCG). Do not round tiny values down to 0.0 mIU/ml; any measured value less than or equal to 0.1 mIU/ml should be coded 001. For values greater than 001 mIU/ml, round values to the nearest mIU/ml. Note 5: A lab value expressed in International Units/liter (IU/L) is equivalent to the same value expressed in milli-International Units/milliliter (mIU/ml). Note 6: If the initial post-orchiectomy hCG test remains elevated, review the subsequent tests until normalization or plateau occurs and use that test to code this field. See Part I for further explanation of serum tumor marker half life. Note 7: If the post-orchiectomy hCG test is done but the actual value is not stated, use code 997. Note 8: For rare cases that are treated prior to orchiectomy or an orchiectomy is not performed, code the initial hCG lab value in this field and not in CS Site-Specific Factor 8. Code Description 000 0 milli-International Units (mIU/ml) 001 002 003 004 005 50 - 59 mIU/ml 006 60 - 69 mIU/ml 007 70 - 79 mIU/ml 008 80 - 89 mIU/ml 009 90 - 99 mIU/ml 010 100 - 199 mIU/ml 020 200 - 299 mIU/ml 030 300 - 399 mIU/ml 040 400 - 499 mIU/ml 050 500 - 599 mIU/ml 060 600 - 699 mIU/ml 070 700 - 799 mIU/ml 080 800 - 899 mIU/ml 090 900 - 999 mIU/ml 100 1000 - 1999 mIU/ml 120 2000 - 2999 mIU/ml 130 3000 - 3999 mIU/ml 140 4000 - 4999 mIU/ml 150 5000 - 5999 mIU/ml 160 6000 - 6999 mIU/ml 170 7000 - 7999 mIU/ml 180 8000 - 8999 mIU/ml 190 9000 - 9999 mIU/ml 200 10, 000 - 19, 999 mIU/ml 220 20, 000 - 29, 999 mIU/ml 230 30, 000 - 39, 999 mIU/ml 240 40, 000 - 49, 999 mIU/ml 250 Greater than or equal to 50,000 mIU/ml 988 997 Test ordered, results not in chart 998 Test not done (test not ordered and not performed) 999 CS Site-Specific Factor 15 Post-Orchiectomy Human Chorionic Gonadotropin (hCG) Range Note 1: Record the range of the human chorionic gonadotropin (hCG) test as documented in the patient record after orchiectomy and prior to further treatment. Note 2: Use the same laboratory test to record values in CS Site-Specific Factors 14 and 15. Note 3: A lab value expressed in International Units/liter (IU/L) is equivalent to the same value expressed in milli-International Units/milliliter (mIU/ml). Note 4: If the initial post-orchiectomy hCG test remains elevated, review the subsequent tests until normalization or plateau occurs and use that test to code this field. See Part I for further explanation of serum tumor marker half life. Note 5: If the post-orchiectomy hCG test is unknown but the preorchiectomy hCG test was normal, use code 990. Note 6: If the post-orchiectomy hCG test is unavailable but a physician's statement of the result is documented, use codes 991-993. Note 7: For rare cases that are treated prior to orchiectomy or an orchiectomy is not performed, code the initial hCG range in this field and not in CS Site-Specific Factor 9. Code Description 000 Within normal limits (S0) 010 020 030 988 990 Post-orchiectomy human chorionic gonadotropic (hCG) unknown but preorchiectomy hCG was normal 991 Post-orchiectomy hCG stated to be still elevated 992 Post-orchiectomy hCG unknown but post-orchiectomy serum tumor markers NOS stated to be normal 993 997 Test ordered, results not in chart 998 Test not done (test not ordered and not performed) 999 CS Site-Specific Factor 16 Post-Orchiectomy Lactate Dehydrogenase (LDH) Range Note 1: Of the three tumor markers, lactate dehydrogenase (LDH) is the least specific for testicular cancer and is more of a determinant of bulky or disseminated disease. Although recommended to be tested, LDH may not be routinely performed, especially if the primary is localized. Note 2: Record the range of the LDH test as documented in the patient record after orchiectomy and prior to further treatment. Note 3: If the initial post-orchiectomy LDH test remains elevated, review the subsequent tests until normalization or plateau occurs and use that test to code this field. See Part I for further explanation of serum tumor marker half life. Note 4: If the post-orchiectomy LDH test is unknown but the preorchiectomy LDH test was normal, use code 990. Note 5: If the post-orchiectomy LDH test is unavailable but a physician's statement of the result is documented, use codes 991-993. Note 6: For rare cases that are treated prior to orchiectomy or an orchiectomy is not performed, code the initial LDH range in this field and not in CS Site-Specific Factor 10. Code Description 000 Within normal limits (S0) 010 020 030 988 990 Postorchiectomy LDH unknown but preorchiectomy LDH was normal 991 Postorchiectomy LDH stated to be still elevated 992 Postorchiectomy LDH unknown but post-orchiectomy serum tumor markers NOS stated to be normal 993 997 Test ordered, results not in chart 998 Test not done (test not ordered and not performed) 999 ¬appnewssf17; ¬appnewssf18; ¬appnewssf19; ¬appnewssf20; ¬appnewssf21; ¬appnewssf22; ¬appnewssf23; ¬appnewssf24; ¬appnewssf25; &commonhistinclusioncarcinomaplusgermcellandtrophoblastic; Histology Exclusion Table AJCC 6th ed. Note: Histology codes listed in this Histology Exclusion Table for this site are codes that are not TNM staged according to the AJCC 6th Edition Cancer Staging Manual. When a case is coded in Collaborative Staging and the histology is on the exclusion list, TNM will not be calculated but SEER algorithm Summary Stage 1977 and 2000 can be assigned. For these cases, displayed results will be "T NA N NA M NA and Stage Group NA". Code Description 8000/0 Neoplasm, benign 8000/1 Neoplasm, uncertain whether benign or malignant 8000/3 Neoplasm, malignant 8000/6 Neoplasm, metastatic 8000/9 Neoplasm, malignant, uncertain whether primary or metastatic 8001/0 Tumor cells, benign 8001/1 Tumor cells, uncertain whether benign or malignant 8001/3 Tumor cells, malignant 8002/3 Malignant tumor, small cell type 8003/3 Malignant tumor, giant cell type 8004/3 Malignant tumor, spindle cell type 8005/0 Clear cell tumor, NOS 8005/3 Malignant tumor, clear cell type 8010/0 Epithelial tumor, benign 8010/2 Carcinoma in situ, NOS 8010/3 Carcinoma, NOS 8010/6 Carcinoma, metastatic, NOS 8010/9 Carcinomatosis 8011/0 Epithelioma, benign 8011/3 Epithelioma, malignant 8012/3 Large cell carcinoma, NOS 8013/3 Large cell neuroendocrine carcinoma 8014/3 Large cell carcinoma with rhabdoid phenotype 8015/3 Glassy cell carcinoma 8020/3 Carcinoma, undifferentiated, NOS 8021/3 Carcinoma, anaplastic, NOS 8022/3 Pleomorphic carcinoma 8030/3 Giant cell and spindle cell carcinoma 8031/3 Giant cell carcinoma 8032/3 Spindle cell carcinoma, NOS 8033/3 Pseudosarcomatous carcinoma 8034/3 Polygonal cell carcinoma 8035/3 Carcinoma with osteoclast-like giant cells 8040/0 Tumorlet, benign 8040/1 Tumorlet, NOS 8041/3 Small cell carcinoma, NOS 8042/3 Oat cell carcinoma (C34._) 8043/3 Small cell carcinoma, fusiform cell 8044/3 Small cell carcinoma, intermediate cell 8045/3 Combined small cell carcinoma 8046/3 Non-small cell carcinoma (C34._) 8050/0 Papilloma, NOS (except papilloma of bladder M-8120/1) 8050/2 Papillary carcinoma in situ 8050/3 Papillary carcinoma, NOS 8051/0 Verrucous papilloma 8051/3 Verrucous carcinoma, NOS 8052/0 Squamous cell papilloma, NOS 8052/2 Papillary squamous cell carcinoma, non-invasive 8052/3 Papillary squamous cell carcinoma 8053/0 Squamous cell papilloma, inverted 8060/0 Squamous papillomatosis 8070/2 Squamous cell carcinoma in situ, NOS 8070/3 Squamous cell carcinoma, NOS 8070/6 Squamous cell carcinoma, metastatic, NOS 8071/3 Squamous cell carcinoma, keratinizing, NOS 8072/3 Squamous cell carcinoma, large cell, nonkeratinizing, NOS 8073/3 Squamous cell carcinoma, small cell, nonkeratinizing 8074/3 Squamous cell carcinoma, spindle cell 8075/3 Squamous cell carcinoma, adenoid 8076/2 Squamous cell carcinoma in situ with questionable stromal invasion 8076/3 Squamous cell carcinoma, microinvasive 8077/2 Squamous intraepithelial neoplasia, grade III 8078/3 Squamous cell carcinoma with horn formation 8080/2 Queyrat erythroplasia (C60._) 8081/2 Bowen disease (C44._) 8082/3 Lymphoepithelial carcinoma 8083/3 Basaloid squamous cell carcinoma 8084/3 Squamous cell carcinoma, clear cell type 8090/1 Basal cell tumor (C44._) 8090/3 Basal cell carcinoma, NOS (C44._) 8091/3 Multifocal superficial basal cell carcinoma (C44._) 8092/3 Infiltrating basal cell carcinoma, NOS (C44._) 8093/3 Basal cell carcinoma, fibroepithelial (C44._) 8094/3 Basosquamous carcinoma (C44._) 8095/3 Metatypical carcinoma (C44._) 8096/0 Intraepidermal epithelioma of Jadassohn (C44._) 8097/3 Basal cell carcinoma, nodular (C44._) 8098/3 Adenoid basal carcinoma (C53._) 8100/0 Trichoepithelioma (C44._) 8101/0 Trichofolliculoma (C44._) 8102/0 Trichilemmoma (C44._) 8102/3 Trichilemmocarcinoma (C44._) 8103/0 Pilar tumor (C44._) 8110/0 Pilomatrixoma, NOS (C44._) 8110/3 Pilomatrix carcinoma (C44._) 8120/0 Transitional cell papilloma, benign 8120/1 Urothelial papilloma, NOS 8120/2 Transitional cell carcinoma in situ 8120/3 Transitional cell carcinoma, NOS 8121/0 Schneiderian papilloma, NOS (C30.0, C31._) 8121/1 Transitional cell papilloma, inverted, NOS 8121/3 Schneiderian carcinoma (C30.0, C31._) 8122/3 Transitional cell carcinoma, spindle cell 8123/3 Basaloid carcinoma 8124/3 Cloacogenic carcinoma (C21.2) 8130/1 Papillary transitional cell neoplasm of low malignant potential (C67._) 8130/2 Papillary transitional cell carcinoma, non-invasive (C67._) 8130/3 Papillary transitional cell carcinoma (C67._) 8131/3 Transitional cell carcinoma, micropapillary (C67._) 8140/0 Adenoma, NOS 8140/1 Atypical adenoma 8140/2 Adenocarcinoma in situ, NOS 8140/3 Adenocarcinoma, NOS 8140/6 Adenocarcinoma, metastatic, NOS 8141/3 Scirrhous adenocarcinoma 8142/3 Linitis plastica (C16._) 8143/3 Superficial spreading adenocarcinoma 8144/3 Adenocarcinoma, intestinal type (C16._) 8145/3 Carcinoma, diffuse type (C16._) 8146/0 Monomorphic adenoma 8147/0 Basal cell adenoma 8147/3 Basal cell adenocarcinoma 8148/2 Glandular intraepithelial neoplasia, grade III 8149/0 Canalicular adenoma 8150/0 Islet cell adenoma (C25._) 8150/1 Islet cell tumor, NOS (C25._) 8150/3 Islet cell carcinoma (C25._) 8151/0 Insulinoma, NOS (C25._) 8151/3 Insulinoma, malignant (C25._) 8152/1 Glucagonoma, NOS (C25._) 8152/3 Glucagonoma, malignant (C25._) 8153/1 Gastrinoma, NOS 8153/3 Gastrinoma, malignant 8154/3 Mixed islet cell and exocrine adenocarcinoma (C25._) 8155/1 Vipoma, NOS 8155/3 Vipoma, malignant 8156/1 Somatostatinoma, NOS 8156/3 Somatostatinoma, malignant 8157/1 Enteroglucagonoma, NOS 8157/3 Enteroglucagonoma, malignant 8160/0 Bile duct adenoma (C22.1, C24.0) 8160/3 Cholangiocarcinoma (C22.1, C24.0) 8161/0 Bile duct cystadenoma (C22.1, C24.0) 8161/3 Bile duct cystadenocarcinoma (C22.1, C24.0) 8162/3 Klatskin tumor (C22.1, C24.0) 8170/0 Liver cell adenoma (C22.0) 8170/3 Hepatocellular carcinoma, NOS (C22.0) 8171/3 Hepatocellular carcinoma, fibrolamellar (C22.0) 8172/3 Hepatocellular carcinoma, scirrhous (C22.0) 8173/3 Hepatocellular carcinoma, spindle cell variant (C22.0) 8174/3 Hepatocellular carcinoma, clear cell type (C22.0) 8175/3 Hepatocellular carcinoma, pleomorphic type (C22.0) 8180/3 Combined hepatocellular carcinoma and cholangiocarcinoma (C22.0) 8190/0 Trabecular adenoma 8190/3 Trabecular adenocarcinoma 8191/0 Embryonal adenoma 8200/0 Eccrine dermal cylindroma (C44._) 8200/3 Adenoid cystic carcinoma 8201/2 Cribriform carcinoma in situ (C50._) 8201/3 Cribriform carcinoma, NOS 8202/0 Microcystic adenoma (C25._) 8204/0 Lactating adenoma (C50._) 8210/0 Adenomatous polyp, NOS 8210/2 Adenocarcinoma in situ in adenomatous polyp 8210/3 Adenocarcinoma in adenomatous polyp 8211/0 Tubular adenoma, NOS 8211/3 Tubular adenocarcinoma 8212/0 Flat adenoma 8213/0 Serrated adenoma (C18._) 8214/3 Parietal cell carcinoma (C16._) 8215/3 Adenocarcinoma of anal glands (C21.1) 8220/0 Adenomatous polyposis coli (C18._) 8220/3 Adenocarcinoma in adenomatous polyposis coli (C18._) 8221/0 Multiple adenomatous polyps 8221/3 Adenocarcinoma in multiple adenomatous polyps 8230/2 Ductal carcinoma in situ, solid type (C50._) 8230/3 Solid carcinoma, NOS 8231/3 Carcinoma simplex 8240/1 Carcinoid tumor of uncertain malignant potential 8240/3 Carcinoid tumor, NOS (except of appendix M-8240/1) 8241/3 Enterochromaffin cell carcinoid 8242/1 Enterochromaffin-like cell carcinoid, NOS 8242/3 Enterochromaffin-like cell tumor, malignant 8243/3 Goblet cell carcinoid 8244/3 Composite carcinoid 8245/1 Tubular carcinoid 8245/3 Adenocarcinoid tumor 8246/3 Neuroendocrine carcinoma, NOS 8247/3 Merkel cell carcinoma (C44._) 8248/1 Apudoma 8249/3 Atypical carcinoid tumor 8250/1 Pulmonary adenomatosis (C34._) 8250/3 Bronchiolo-alveolar adenocarcinoma, NOS (C34._) 8251/0 Alveolar adenoma (C34._) 8251/3 Alveolar adenocarcinoma (C34._) 8252/3 Bronchiolo-alveolar carcinoma, non-mucinous (C34._) 8253/3 Bronchiolo-alveolar carcinoma, mucinous (C34._) 8254/3 Bronchiolo-alveolar carcinoma, mixed mucinous and non-mucinous (C34._) 8255/3 Adenocarcinoma with mixed subtypes 8260/0 Papillary adenoma, NOS 8260/3 Papillary adenocarcinoma, NOS 8261/0 Villous adenoma, NOS 8261/2 Adenocarcinoma in situ in villous adenoma 8261/3 Adenocarcinoma in villous adenoma 8262/3 Villous adenocarcinoma 8263/0 Tubulovillous adenoma, NOS 8263/2 Adenocarcinoma in situ in tubulovillous adenoma 8263/3 Adenocarcinoma in tubulovillous adenoma 8264/0 Papillomatosis, glandular 8270/0 Chromophobe adenoma (C75.1) 8270/3 Chromophobe carcinoma (C75.1) 8271/0 Prolactinoma (C75.1) 8272/0 Pituitary adenoma, NOS (C75.1) 8272/3 Pituitary carcinoma, NOS (C75.1) 8280/0 Acidophil adenoma (C75.1) 8280/3 Acidophil carcinoma (C75.1) 8281/0 Mixed acidophil-basophil adenoma (C75.1) 8281/3 Mixed acidophil-basophil carcinoma (C75.1) 8290/0 Oxyphilic adenoma 8290/3 Oxyphilic adenocarcinoma 8300/0 Basophil adenoma (C75.1) 8300/3 Basophil carcinoma (C75.1) 8310/0 Clear cell adenoma 8310/3 Clear cell adenocarcinoma, NOS 8311/1 Hypernephroid tumor [obs] 8312/3 Renal cell carcinoma, NOS (C64.9) 8313/0 Clear cell adenofibroma (C56.9) 8313/1 Clear cell adenofibroma of borderline malignancy (C56.9) 8313/3 Clear cell adenocarcinofibroma (C56.9) 8314/3 Lipid-rich carcinoma (C50._) 8315/3 Glycogen-rich carcinoma 8316/3 Cyst-associated renal cell carcinoma (C64.9) 8317/3 Renal cell carcinoma, chromophobe type (C64.9) 8318/3 Renal cell carcinoma, sarcomatoid (C64.9) 8319/3 Collecting duct carcinoma (C64.9) 8320/3 Granular cell carcinoma 8321/0 Chief cell adenoma (C75.0) 8322/0 Water-clear cell adenoma (C75.0) 8322/3 Water-clear cell adenocarcinoma (C75.0) 8323/0 Mixed cell adenoma 8323/3 Mixed cell adenocarcinoma 8324/0 Lipoadenoma 8325/0 Metanephric adenoma (C64.9) 8330/0 Follicular adenoma (C73.9) 8330/1 Atypical follicular adenoma (C73.9) 8330/3 Follicular adenocarcinoma, NOS (C73.9) 8331/3 Follicular adenocarcinoma, well differentiated (C73.9) 8332/3 Follicular adenocarcinoma, trabecular (C73.9) 8333/0 Microfollicular adenoma, NOS (C73.9) 8333/3 Fetal adenocarcinoma 8334/0 Macrofollicular adenoma (C73.9) 8335/3 Follicular carcinoma, minimally invasive (C73.9) 8336/0 Hyalinizing trabecular adenoma (C73.9) 8337/3 Insular carcinoma (C73.9) 8340/3 Papillary carcinoma, follicular variant (C73.9) 8341/3 Papillary microcarcinoma (C73.9) 8342/3 Papillary carcinoma, oxyphilic cell (C73.9) 8343/3 Papillary carcinoma, encapsulated (C73.9) 8344/3 Papillary carcinoma, columnar cell (C73.9) 8345/3 Medullary carcinoma with amyloid stroma (C73.9) 8346/3 Mixed medullary-follicular carcinoma (C73.9) 8347/3 Mixed medullary-papillary carcinoma (C73.9) 8350/3 Nonencapsulated sclerosing carcinoma (C73.9) 8360/1 Multiple endocrine adenomas 8361/0 Juxtaglomerular tumor (C64.9) 8370/0 Adrenal cortical adenoma, NOS (C74.0) 8370/3 Adrenal cortical carcinoma (C74.0) 8371/0 Adrenal cortical adenoma, compact cell (C74.0) 8372/0 Adrenal cortical adenoma, pigmented (C74.0) 8373/0 Adrenal cortical adenoma, clear cell (C74.0) 8374/0 Adrenal cortical adenoma, glomerulosa cell (C74.0) 8375/0 Adrenal cortical adenoma, mixed cell (C74.0) 8380/0 Endometrioid adenoma, NOS 8380/1 Endometrioid adenoma, borderline malignancy 8380/3 Endometrioid adenocarcinoma, NOS 8381/0 Endometrioid adenofibroma, NOS 8381/1 Endometrioid adenofibroma, borderline malignancy 8381/3 Endometrioid adenofibroma, malignant 8382/3 Endometrioid adenocarcinoma, secretory variant 8383/3 Endometrioid adenocarcinoma, ciliated cell variant 8384/3 Adenocarcinoma, endocervical type 8390/0 Skin appendage adenoma (C44._) 8390/3 Skin appendage carcinoma (C44._) 8391/0 Follicular fibroma (C44._) 8392/0 Syringofibroadenoma (C44._) 8400/0 Sweat gland adenoma (C44._) 8400/1 Sweat gland tumor, NOS (C44._) 8400/3 Sweat gland adenocarcinoma (C44._) 8401/0 Apocrine adenoma 8401/3 Apocrine adenocarcinoma 8402/0 Nodular hidradenoma (C44._) 8402/3 Nodular hidradenoma, malignant (C44._) 8403/0 Eccrine spiradenoma (C44._) 8403/3 Malignant eccrine spiradenoma (C44._) 8404/0 Hidrocystoma (C44._) 8405/0 Papillary hidradenoma 8406/0 Papillary syringadenoma (C44._) 8407/0 Syringoma, NOS (C44._) 8407/3 Sclerosing sweat duct carcinoma (C44._) 8408/0 Eccrine papillary adenoma (C44._) 8408/1 Aggressive digital papillary adenoma (C44._) 8408/3 Eccrine papillary adenocarcinoma (C44._) 8409/0 Eccrine poroma (C44._) 8409/3 Eccrine poroma, malignant 8410/0 Sebaceous adenoma (C44._) 8410/3 Sebaceous adenocarcinoma (C44._) 8413/3 Eccrine adenocarcinoma (C44._) 8420/0 Ceruminous adenoma (C44.2) 8420/3 Ceruminous adenocarcinoma (C44.2) 8430/1 Mucoepidermoid tumor [obs] 8430/3 Mucoepidermoid carcinoma 8440/0 Cystadenoma, NOS 8440/3 Cystadenocarcinoma, NOS 8441/0 Serous cystadenoma, NOS 8441/3 Serous cystadenocarcinoma, NOS (C56.9) 8442/1 Serous cystadenoma, borderline malignancy (C56.9) 8443/0 Clear cell cystadenoma (C56.9) 8444/1 Clear cell cystic tumor of borderline malignancy (C56.9) 8450/0 Papillary cystadenoma, NOS (C56.9) 8450/3 Papillary cystadenocarcinoma, NOS (C56.9) 8451/1 Papillary cystadenoma, borderline malignancy (C56.9) 8452/1 Solid pseudopapillary tumor (C25._) 8452/3 Solid pseudopapillary carcinoma (C25._) 8453/0 Intraductal papillary-mucinous adenoma (C25._) 8453/1 Intraductal papillary-mucinous tumor with moderate dysplasia (C25._) 8453/2 Intraductal papillary-mucinous carcinoma, non-invasive (C25._) 8453/3 Intraductal papillary-mucinous carcinoma, invasive (C25._) 8454/0 Cystic tumor of atrio-ventricular node (C38.0) 8460/0 Papillary serous cystadenoma, NOS (C56.9) 8460/3 Papillary serous cystadenocarcinoma (C56.9) 8461/0 Serous surface papilloma (C56.9) 8461/3 Serous surface papillary carcinoma (C56.9) 8462/1 Serous papillary cystic tumor of borderline malignancy (C56.9) 8463/1 Serous surface papillary tumor of borderline malignancy (C56.9) 8470/0 Mucinous cystadenoma, NOS (C56.9) 8470/1 Mucinous cystic tumor with moderate dysplasia (C25._) 8470/2 Mucinous cystadenocarcinoma, non-invasive (C25._) 8470/3 Mucinous cystadenocarcinoma, NOS (C56.9) 8471/0 Papillary mucinous cystadenoma, NOS (C56.9) 8471/3 Papillary mucinous cystadenocarcinoma (C56.9) 8472/1 Mucinous cystic tumor of borderline malignancy (C56.9) 8473/1 Papillary mucinous cystadenoma, borderline malignancy (C56.9) 8480/0 Mucinous adenoma 8480/3 Mucinous adenocarcinoma 8480/6 Pseudomyxoma peritonei 8481/3 Mucin-producing adenocarcinoma 8482/3 Mucinous adenocarcinoma, endocervical type 8490/3 Signet ring cell carcinoma 8490/6 Metastatic signet ring cell carcinoma 8500/2 Intraductal carcinoma, noninfiltrating, NOS 8500/3 Infiltrating duct carcinoma, NOS (C50._) 8501/2 Comedocarcinoma, noninfiltrating (C50._) 8501/3 Comedocarcinoma, NOS (C50._) 8502/3 Secretory carcinoma of breast (C50._) 8503/0 Intraductal papilloma 8503/2 Noninfiltrating intraductal papillary adenocarcinoma (C50._) 8503/3 Intraductal papillary adenocarcinoma with invasion (C50._) 8504/0 Intracystic papillary adenoma 8504/2 Noninfiltrating intracystic carcinoma 8504/3 Intracystic carcinoma, NOS 8505/0 Intraductal papillomatosis, NOS 8506/0 Adenoma of nipple (C50.0) 8507/2 Intraductal micropapillary carcinoma (C50._) 8508/3 Cystic hypersecretory carcinoma (C50._) 8510/3 Medullary carcinoma, NOS 8512/3 Medullary carcinoma with lymphoid stroma 8513/3 Atypical medullary carcinoma (C50._) 8514/3 Duct carcinoma, desmoplastic type 8520/2 Lobular carcinoma in situ, NOS (C50._) 8520/3 Lobular carcinoma, NOS (C50._) 8521/3 Infiltrating ductular carcinoma (C50._) 8522/2 Intraductal carcinoma and lobular carcinoma in situ (C50._) 8522/3 Infiltrating duct and lobular carcinoma (C50._) 8523/3 Infiltrating duct mixed with other types of carcinoma (C50._) 8524/3 Infiltrating lobular mixed with other types of carcinoma (C50._) 8525/3 Polymorphous low grade adenocarcinoma 8530/3 Inflammatory carcinoma (C50._) 8540/3 Paget disease, mammary (C50._) 8541/3 Paget disease and infiltrating duct carcinoma of breast (C50._) 8542/3 Paget disease, extramammary (except Paget disease of bone) 8543/3 Paget disease and intraductal carcinoma of breast (C50._) 8550/0 Acinar cell adenoma 8550/1 Acinar cell tumor [obs] 8550/3 Acinar cell carcinoma 8551/3 Acinar cell cystadenocarcinoma 8560/0 Mixed squamous cell and glandular papilloma 8560/3 Adenosquamous carcinoma 8561/0 Adenolymphoma (C07._, C08._) 8562/3 Epithelial-myoepithelial carcinoma 8570/3 Adenocarcinoma with squamous metaplasia 8571/3 Adenocarcinoma with cartilaginous and osseous metaplasia 8572/3 Adenocarcinoma with spindle cell metaplasia 8573/3 Adenocarcinoma with apocrine metaplasia 8574/3 Adenocarcinoma with neuroendocrine differentiation 8575/3 Metaplastic carcinoma, NOS 8576/3 Hepatoid adenocarcinoma 8580/0 Thymoma, benign (C37.9) 8580/1 Thymoma, NOS (C37.9) 8580/3 Thymoma, malignant, NOS (C37.9) 8581/1 Thymoma, type A, NOS (C37.9) 8581/3 Thymoma, type A, malignant (C37.9) 8582/1 Thymoma, type AB, NOS (C37.9) 8582/3 Thymoma, type AB, malignant (C37.9) 8583/1 Thymoma, type B1, NOS (C37.9) 8583/3 Thymoma, type B1, malignant (C37.9) 8584/1 Thymoma, type B2, NOS (C37.9) 8584/3 Thymoma, type B2, malignant (C37.9) 8585/1 Thymoma, type B3, NOS (C37.9) 8585/3 Thymoma, type B3, malignant (C37.9) 8586/3 Thymic carcinoma, NOS (C37.9) 8587/0 Ectopic hamartomatous thymoma 8588/3 Spindle epithelial tumor with thymus-like element 8589/3 Carcinoma showing thymus-like element 8660/0 Hilus cell tumor (C56.9) 8670/0 Lipid cell tumor of ovary (C56.9) 8670/3 Steroid cell tumor, malignant 8671/0 Adrenal rest tumor 8680/0 Paraganglioma, benign 8680/1 Paraganglioma, NOS 8680/3 Paraganglioma, malignant 8681/1 Sympathetic paraganglioma 8682/1 Parasympathetic paraganglioma 8683/0 Gangliocytic paraganglioma (C17.0) 8690/1 Glomus jugulare tumor, NOS (C75.5) 8691/1 Aortic body tumor (C75.5) 8692/1 Carotid body tumor (C75.4) 8693/1 Extra-adrenal paraganglioma, NOS 8693/3 Extra-adrenal paraganglioma, malignant 8700/0 Pheochromocytoma, NOS (C74.1) 8700/3 Pheochromocytoma, malignant (C74.1) 8710/3 Glomangiosarcoma 8711/0 Glomus tumor, NOS 8711/3 Glomus tumor, malignant 8712/0 Glomangioma 8713/0 Glomangiomyoma 8720/0 Pigmented nevus, NOS (C44._) 8720/2 Melanoma in situ 8720/3 Malignant melanoma, NOS (except juvenile melanoma M-8770/0) 8721/3 Nodular melanoma (C44._) 8722/0 Balloon cell nevus (C44._) 8722/3 Balloon cell melanoma (C44._) 8723/0 Halo nevus (C44._) 8723/3 Malignant melanoma, regressing (C44._) 8725/0 Neuronevus (C44._) 8726/0 Magnocellular nevus (C69.4) 8727/0 Dysplastic nevus (C44._) 8728/0 Diffuse melanocytosis (C70.9) 8728/1 Meningeal melanocytoma (C70.9) 8728/3 Meningeal melanomatosis (C70.9) 8730/0 Nonpigmented nevus (C44._) 8730/3 Amelanotic melanoma (C44._) 8740/0 Junctional nevus, NOS (C44._) 8740/3 Malignant melanoma in junctional nevus (C44._) 8741/2 Precancerous melanosis, NOS (C44._) 8741/3 Malignant melanoma in precancerous melanosis (C44._) 8742/2 Lentigo maligna (C44._) 8742/3 Lentigo maligna melanoma (C44._) 8743/3 Superficial spreading melanoma (C44._) 8744/3 Acral lentiginous melanoma, malignant (C44._) 8745/3 Desmoplastic melanoma, malignant (C44._) 8746/3 Mucosal lentiginous melanoma 8750/0 Intradermal nevus (C44._) 8760/0 Compound nevus (C44._) 8761/0 Small congenital nevus (C44._) 8761/1 Giant pigmented nevus, NOS (C44._) 8761/3 Malignant melanoma in giant pigmented nevus (C44._) 8762/1 Proliferative dermal lesion in congenital nevus (C44._) 8770/0 Epithelioid and spindle cell nevus (C44._) 8770/3 Mixed epithelioid and spindle cell melanoma 8771/0 Epithelioid cell nevus (C44._) 8771/3 Epithelioid cell melanoma 8772/0 Spindle cell nevus, NOS (C44._) 8772/3 Spindle cell melanoma, NOS 8773/3 Spindle cell melanoma, type A (C69._) 8774/3 Spindle cell melanoma, type B (C69._) 8780/0 Blue nevus, NOS (C44._) 8780/3 Blue nevus, malignant (C44._) 8790/0 Cellular blue nevus (C44._) 8800/0 Soft tissue tumor, benign 8800/3 Sarcoma, NOS 8800/9 Sarcomatosis, NOS 8801/3 Spindle cell sarcoma 8802/3 Giant cell sarcoma (except of bone M-9250/3) 8803/3 Small cell sarcoma 8804/3 Epithelioid sarcoma 8805/3 Undifferentiated sarcoma 8806/3 Desmoplastic small round cell tumor 8810/0 Fibroma, NOS 8810/1 Cellular fibroma (C56.9) 8810/3 Fibrosarcoma, NOS 8811/0 Fibromyxoma 8811/3 Fibromyxosarcoma 8812/0 Periosteal fibroma (C40._, C41._) 8812/3 Periosteal fibrosarcoma (C40._, C41._) 8813/0 Fascial fibroma 8813/3 Fascial fibrosarcoma 8814/3 Infantile fibrosarcoma 8815/0 Solitary fibrous tumor 8815/3 Solitary fibrous tumor, malignant 8820/0 Elastofibroma 8821/1 Aggressive fibromatosis 8822/1 Abdominal fibromatosis 8823/0 Desmoplastic fibroma 8824/0 Myofibroma 8824/1 Myofibromatosis 8825/0 Myofibroblastoma 8825/1 Myofibroblastic tumor, NOS 8826/0 Angiomyofibroblastoma 8827/1 Myofibroblastic tumor, peribronchial (C34._) 8830/0 Benign fibrous histiocytoma 8830/1 Atypical fibrous histiocytoma 8830/3 Malignant fibrous histiocytoma 8831/0 Histiocytoma, NOS 8832/0 Dermatofibroma, NOS (C44._) 8832/3 Dermatofibrosarcoma, NOS (C44._) 8833/3 Pigmented dermatofibrosarcoma protuberans (C44._) 8834/1 Giant cell fibroblastoma 8835/1 Plexiform fibrohistiocytic tumor 8836/1 Angiomatoid fibrous histiocytoma 8840/0 Myxoma, NOS 8840/3 Myxosarcoma 8841/1 Angiomyxoma 8842/0 Ossifying fibromyxoid tumor 8850/0 Lipoma, NOS 8850/1 Atypical lipoma 8850/3 Liposarcoma, NOS 8851/0 Fibrolipoma 8851/3 Liposarcoma, well differentiated 8852/0 Fibromyxolipoma 8852/3 Myxoid liposarcoma 8853/3 Round cell liposarcoma 8854/0 Pleomorphic lipoma 8854/3 Pleomorphic liposarcoma 8855/3 Mixed liposarcoma 8856/0 Intramuscular lipoma 8857/0 Spindle cell lipoma 8857/3 Fibroblastic liposarcoma 8858/3 Dedifferentiated liposarcoma 8860/0 Angiomyolipoma 8861/0 Angiolipoma, NOS 8862/0 Chondroid lipoma 8870/0 Myelolipoma 8880/0 Hibernoma 8881/0 Lipoblastomatosis 8890/0 Leiomyoma, NOS 8890/1 Leiomyomatosis, NOS 8890/3 Leiomyosarcoma, NOS 8891/0 Epithelioid leiomyoma 8891/3 Epithelioid leiomyosarcoma 8892/0 Cellular leiomyoma 8893/0 Bizarre leiomyoma 8894/0 Angiomyoma 8894/3 Angiomyosarcoma 8895/0 Myoma 8895/3 Myosarcoma 8896/3 Myxoid leiomyosarcoma 8897/1 Smooth muscle tumor of uncertain malignant potential 8898/1 Metastasizing leiomyoma 8900/0 Rhabdomyoma, NOS 8900/3 Rhabdomyosarcoma, NOS 8901/3 Pleomorphic rhabdomyosarcoma, adult type 8902/3 Mixed type rhabdomyosarcoma 8903/0 Fetal rhabdomyoma 8904/0 Adult rhabdomyoma 8905/0 Genital rhabdomyoma (C51._, C52.9) 8910/3 Embryonal rhabdomyosarcoma, NOS 8912/3 Spindle cell rhabdomyosarcoma 8920/3 Alveolar rhabdomyosarcoma 8921/3 Rhabdomyosarcoma with ganglionic differentiation 8930/0 Endometrial stromal nodule (C54.1) 8930/3 Endometrial stromal sarcoma, NOS (C54.1) 8931/3 Endometrial stromal sarcoma, low grade (C54.1) 8932/0 Adenomyoma 8933/3 Adenosarcoma 8934/3 Carcinofibroma 8935/0 Stromal tumor, benign 8935/1 Stromal tumor, NOS 8935/3 Stromal sarcoma, NOS 8936/0 Gastrointestinal stromal tumor, benign 8936/1 Gastrointestinal stromal tumor, NOS 8936/3 Gastrointestinal stromal sarcoma 8940/0 Pleomorphic adenoma 8940/3 Mixed tumor, malignant, NOS 8941/3 Carcinoma in pleomorphic adenoma (C07._, C08._) 8950/3 Mullerian mixed tumor (C54._) 8951/3 Mesodermal mixed tumor 8959/0 Benign cystic nephroma (C64.9) 8959/1 Cystic partially differentiated nephroblastoma (C64.9) 8959/3 Malignant cystic nephroma (C64.9) 8960/1 Mesoblastic nephroma 8960/3 Nephroblastoma, NOS (C64.9) 8963/3 Malignant rhabdoid tumor 8964/3 Clear cell sarcoma of kidney (C64.9) 8965/0 Nephrogenic adenofibroma (C64.9) 8966/0 Renomedullary interstitial cell tumor (C64.9) 8967/0 Ossifying renal tumor (C64.9) 8970/3 Hepatoblastoma (C22.0) 8971/3 Pancreatoblastoma (C25._) 8972/3 Pulmonary blastoma (C34._) 8973/3 Pleuropulmonary blastoma 8974/1 Sialoblastoma 8980/3 Carcinosarcoma, NOS 8981/3 Carcinosarcoma, embryonal 8982/0 Myoepithelioma 8982/3 Malignant myoepithelioma 8983/0 Adenomyoepithelioma (C50._) 8990/0 Mesenchymoma, benign 8990/1 Mesenchymoma, NOS 8990/3 Mesenchymoma, malignant 8991/3 Embryonal sarcoma 9000/0 Brenner tumor, NOS (C56.9) 9000/1 Brenner tumor, borderline malignancy (C56.9) 9000/3 Brenner tumor, malignant (C56.9) 9010/0 Fibroadenoma, NOS (C50._) 9011/0 Intracanalicular fibroadenoma (C50._) 9012/0 Pericanalicular fibroadenoma (C50._) 9013/0 Adenofibroma, NOS 9014/0 Serous adenofibroma, NOS 9014/1 Serous adenofibroma of borderline malignancy 9014/3 Serous adenocarcinofibroma 9015/0 Mucinous adenofibroma, NOS 9015/1 Mucinous adenofibroma of borderline malignancy 9015/3 Mucinous adenocarcinofibroma 9016/0 Giant fibroadenoma (C50._) 9020/0 Phyllodes tumor, benign (C50._) 9020/1 Phyllodes tumor, borderline (C50._) 9020/3 Phyllodes tumor, malignant (C50._) 9030/0 Juvenile fibroadenoma (C50._) 9040/0 Synovioma, benign 9040/3 Synovial sarcoma, NOS 9041/3 Synovial sarcoma, spindle cell 9042/3 Synovial sarcoma, epithelioid cell 9043/3 Synovial sarcoma, biphasic 9044/3 Clear cell sarcoma, NOS (except of kidney M-8964/3) 9050/0 Mesothelioma, benign 9050/3 Mesothelioma, malignant 9051/0 Fibrous mesothelioma, benign 9051/3 Fibrous mesothelioma, malignant 9052/0 Epithelioid mesothelioma, benign 9052/3 Epithelioid mesothelioma, malignant 9053/3 Mesothelioma, biphasic, malignant 9054/0 Adenomatoid tumor, NOS 9055/0 Multicystic mesothelioma, benign 9055/1 Cystic mesothelioma, NOS (C48._) 9102/3 Malignant teratoma, trophoblastic 9103/0 Partial hydatidiform mole (C58.9) 9104/1 Placental site trophoblastic tumor (C58.9) 9105/3 Trophoblastic tumor, epithelioid 9110/0 Mesonephroma, benign 9110/1 Mesonephric tumor, NOS 9110/3 Mesonephroma, malignant 9120/0 Hemangioma, NOS 9120/3 Hemangiosarcoma 9121/0 Cavernous hemangioma 9122/0 Venous hemangioma 9123/0 Racemose hemangioma 9124/3 Kupffer cell sarcoma (C22.0) 9125/0 Epithelioid hemangioma 9130/0 Hemangioendothelioma, benign 9130/1 Hemangioendothelioma, NOS 9130/3 Hemangioendothelioma, malignant 9131/0 Capillary hemangioma 9132/0 Intramuscular hemangioma 9133/1 Epithelioid hemangioendothelioma, NOS 9133/3 Epithelioid hemangioendothelioma, malignant 9135/1 Endovascular papillary angioendothelioma 9136/1 Spindle cell hemangioendothelioma 9140/3 Kaposi sarcoma 9141/0 Angiokeratoma 9142/0 Verrucous keratotic hemangioma 9150/0 Hemangiopericytoma, benign 9150/1 Hemangiopericytoma, NOS 9150/3 Hemangiopericytoma, malignant 9160/0 Angiofibroma, NOS 9161/0 Acquired tufted hemangioma 9161/1 Hemangioblastoma 9170/0 Lymphangioma, NOS 9170/3 Lymphangiosarcoma 9171/0 Capillary lymphangioma 9172/0 Cavernous lymphangioma 9173/0 Cystic lymphangioma 9174/0 Lymphangiomyoma 9174/1 Lymphangiomyomatosis 9175/0 Hemolymphangioma 9180/0 Osteoma, NOS (C40._, C41._) 9180/3 Osteosarcoma, NOS (C40._, C41._) 9181/3 Chondroblastic osteosarcoma (C40._, C41._) 9182/3 Fibroblastic osteosarcoma (C40._, C41._) 9183/3 Telangiectatic osteosarcoma (C40._, C41._) 9184/3 Osteosarcoma in Paget disease of bone (C40._, C41._) 9185/3 Small cell osteosarcoma (C40._, C41._) 9186/3 Central osteosarcoma (C40._, C41._) 9187/3 Intraosseous well differentiated osteosarcoma (C40._, C41._) 9191/0 Osteoid osteoma, NOS (C40._, C41._) 9192/3 Parosteal osteosarcoma (C40._, C41._) 9193/3 Periosteal osteosarcoma (C40._, C41._) 9194/3 High grade surface osteosarcoma (C40._, C41._) 9195/3 Intracortical osteosarcoma (C40._, C41._) 9200/0 Osteoblastoma, NOS (C40._, C41._) 9200/1 Aggressive osteoblastoma (C40._, C41._) 9210/0 Osteochondroma (C40._, C41._) 9210/1 Osteochondromatosis, NOS (C40._, C41._) 9220/0 Chondroma, NOS (C40._, C41._) 9220/1 Chondromatosis, NOS 9220/3 Chondrosarcoma, NOS (C40._, C41._) 9221/0 Juxtacortical chondroma (C40._, C41._) 9221/3 Juxtacortical chondrosarcoma (C40._, C41._) 9230/0 Chondroblastoma, NOS (C40._, C41._) 9230/3 Chondroblastoma, malignant (C40._, C41._) 9231/3 Myxoid chondrosarcoma 9240/3 Mesenchymal chondrosarcoma 9241/0 Chondromyxoid fibroma (C40._, C41._) 9242/3 Clear cell chondrosarcoma (C40._, C41._) 9243/3 Dedifferentiated chondrosarcoma (C40._, C41._) 9250/1 Giant cell tumor of bone, NOS (C40._, C41._) 9250/3 Giant cell tumor of bone, malignant (C40._, C41._) 9251/1 Giant cell tumor of soft parts, NOS 9251/3 Malignant giant cell tumor of soft parts 9252/0 Tenosynovial giant cell tumor (C49._) 9252/3 Malignant tenosynovial giant cell tumor (C49._) 9260/3 Ewing sarcoma 9261/3 Adamantinoma of long bones (C40._) 9262/0 Ossifying fibroma 9270/0 Odontogenic tumor, benign 9270/1 Odontogenic tumor, NOS 9270/3 Odontogenic tumor, malignant 9271/0 Ameloblastic fibrodentinoma 9272/0 Cementoma, NOS 9273/0 Cementoblastoma, benign 9274/0 Cementifying fibroma 9275/0 Gigantiform cementoma 9280/0 Odontoma, NOS 9281/0 Compound odontoma 9282/0 Complex odontoma 9290/0 Ameloblastic fibro-odontoma 9290/3 Ameloblastic odontosarcoma 9300/0 Adenomatoid odontogenic tumor 9301/0 Calcifying odontogenic cyst 9302/0 Odontogenic ghost cell tumor 9310/0 Ameloblastoma, NOS 9310/3 Ameloblastoma, malignant 9311/0 Odontoameloblastoma 9312/0 Squamous odontogenic tumor 9320/0 Odontogenic myxoma 9321/0 Central odontogenic fibroma 9322/0 Peripheral odontogenic fibroma 9330/0 Ameloblastic fibroma 9330/3 Ameloblastic fibrosarcoma 9340/0 Calcifying epithelial odontogenic tumor 9341/1 Clear cell odontogenic tumor 9342/3 Odontogenic carcinosarcoma 9350/1 Craniopharyngioma (C75.2) 9351/1 Craniopharyngioma, adamantinomatous (C75.2) 9352/1 Craniopharyngioma, papillary (C75.2) 9360/1 Pinealoma (C75.3) 9361/1 Pineocytoma (C75.3) 9362/3 Pineoblastoma (C75.3) 9363/0 Melanotic neuroectodermal tumor 9364/3 Peripheral neuroectodermal tumor 9365/3 Askin tumor 9370/3 Chordoma, NOS 9371/3 Chondroid chordoma 9372/3 Dedifferentiated chordoma 9373/0 Parachordoma 9380/3 Glioma, malignant (C71._) 9381/3 Gliomatosis cerebri (C71._) 9382/3 Mixed glioma (C71._) 9383/1 Subependymoma (C71._) 9384/1 Subependymal giant cell astrocytoma (C71._) 9390/0 Choroid plexus papilloma, NOS (C71.5) 9390/1 Atypical choroid plexus papilloma (C71.5) 9390/3 Choroid plexus carcinoma (C71.5) 9391/3 Ependymoma, NOS (C71._) 9392/3 Ependymoma, anaplastic (C71._) 9393/3 Papillary ependymoma (C71._) 9394/1 Myxopapillary ependymoma (C72.0) 9400/3 Astrocytoma, NOS (C71._) 9401/3 Astrocytoma, anaplastic (C71._) 9410/3 Protoplasmic astrocytoma (C71._) 9411/3 Gemistocytic astrocytoma (C71._) 9412/1 Desmoplastic infantile astrocytoma (C71._) 9413/0 Dysembryoplastic neuroepithelial tumor 9420/3 Fibrillary astrocytoma (C71._) 9421/1 Pilocytic astrocytoma (C71._) 9423/3 Polar spongioblastoma (C71._) 9424/3 Pleomorphic xanthoastrocytoma (C71._) 9430/3 Astroblastoma (C71._) 9440/3 Glioblastoma, NOS (C71._) 9441/3 Giant cell glioblastoma (C71._) 9442/1 Gliofibroma (C71._) 9442/3 Gliosarcoma (C71._) 9444/1 Chordoid glioma (C71._) 9450/3 Oligodendroglioma, NOS (C71._) 9451/3 Oligodendroglioma, anaplastic (C71._) 9460/3 Oligodendroblastoma (C71._) [obs] 9470/3 Medulloblastoma, NOS (C71.6) 9471/3 Desmoplastic nodular medulloblastoma (C71.6) 9472/3 Medullomyoblastoma (C71.6) 9473/3 Primitive neuroectodermal tumor, NOS 9474/3 Large cell medulloblastoma (C71.6) 9480/3 Cerebellar sarcoma, NOS (C71.6) [obs] 9490/0 Ganglioneuroma 9490/3 Ganglioneuroblastoma 9491/0 Ganglioneuromatosis 9492/0 Gangliocytoma 9493/0 Dysplastic gangliocytoma of cerebellum (Lhermitte-Duclos) (C71.6) 9500/3 Neuroblastoma, NOS 9501/0 Medulloepithelioma, benign (C69.4) 9501/3 Medulloepithelioma, NOS 9502/0 Teratoid medulloepithelioma, benign (C69.4) 9502/3 Teratoid medulloepithelioma 9503/3 Neuroepithelioma, NOS 9504/3 Spongioneuroblastoma 9505/1 Ganglioglioma, NOS 9505/3 Ganglioglioma, anaplastic 9506/1 Central neurocytoma 9507/0 Pacinian tumor 9508/3 Atypical teratoid/rhabdoid tumor (C71._) 9510/0 Retinocytoma (C69.2) 9510/3 Retinoblastoma, NOS (C69.2) 9511/3 Retinoblastoma, differentiated (C69.2) 9512/3 Retinoblastoma, undifferentiated (C69.2) 9513/3 Retinoblastoma, diffuse (C69.2) 9514/1 Retinoblastoma, spontaneously regressed (C69.2) 9520/3 Olfactory neurogenic tumor 9521/3 Olfactory neurocytoma (C30.0) 9522/3 Olfactory neuroblastoma (C30.0) 9523/3 Olfactory neuroepithelioma (C30.0) 9530/0 Meningioma, NOS 9530/1 Meningiomatosis, NOS 9530/3 Meningioma, malignant 9531/0 Meningothelial meningioma 9532/0 Fibrous meningioma 9533/0 Psammomatous meningioma 9534/0 Angiomatous meningioma 9535/0 Hemangioblastic meningioma [obs] 9537/0 Transitional meningioma 9538/1 Clear cell meningioma 9538/3 Papillary meningioma 9539/1 Atypical meningioma 9539/3 Meningeal sarcomatosis 9540/0 Neurofibroma, NOS 9540/1 Neurofibromatosis, NOS 9540/3 Malignant peripheral nerve sheath tumor 9541/0 Melanotic neurofibroma 9550/0 Plexiform neurofibroma 9560/0 Neurilemoma, NOS 9560/1 Neurinomatosis 9560/3 Neurilemoma, malignant [obs] 9561/3 Malignant peripheral nerve sheath tumor with rhabdomyoblastic differentiation 9562/0 Neurothekeoma 9570/0 Neuroma, NOS 9571/0 Perineurioma, NOS 9571/3 Perineurioma, malignant 9580/0 Granular cell tumor, NOS 9580/3 Granular cell tumor, malignant 9581/3 Alveolar soft part sarcoma 9582/0 Granular cell tumor of the sellar region (C75.1) 9590/3 Malignant lymphoma, NOS 9591/3 Malignant lymphoma, non-Hodgkin, NOS 9596/3 Composite Hodgkin and non-Hodgkin lymphoma 9650/3 Hodgkin lymphoma, NOS 9651/3 Hodgkin lymphoma, lymphocyte-rich 9652/3 Hodgkin lymphoma, mixed cellularity, NOS 9653/3 Hodgkin lymphoma, lymphocyte depletion, NOS 9654/3 Hodgkin lymphoma, lymphocyte depletion, diffuse fibrosis 9655/3 Hodgkin lymphoma, lymphocyte depletion, reticular 9659/3 Hodgkin lymphoma, nodular lymphocyte predominance 9661/3 Hodgkin granuloma [obs] 9662/3 Hodgkin sarcoma [obs] 9663/3 Hodgkin lymphoma, nodular sclerosis, NOS 9664/3 Hodgkin lymphoma, nodular sclerosis, cellular phase 9665/3 Hodgkin lymphoma, nodular sclerosis, grade 1 9667/3 Hodgkin lymphoma, nodular sclerosis, grade 2 9673/3 Mantle cell lymphoma 9675/3 Malignant lymphoma, mixed small and large cell, diffuse [obs] (see also M-9690/3) 9678/3 Primary effusion lymphoma 9679/3 Mediastinal large B-cell lymphoma (C38.3) 9680/3 Malignant lymphoma, large B-cell, diffuse, NOS 9684/3 Malignant lymphoma, large B-cell, diffuse, immunoblastic, NOS 9687/3 Burkitt lymphoma, NOS (see also M-9826/3) 9689/3 Splenic marginal zone B-cell lymphoma (C42.2) 9690/3 Follicular lymphoma, NOS (see also M-9675/3) 9691/3 Follicular lymphoma, grade 2 9695/3 Follicular lymphoma, grade 1 9698/3 Follicular lymphoma, grade 3 9699/3 Marginal zone B-cell lymphoma, NOS 9700/3 Mycosis fungoides (C44._) 9701/3 Sezary syndrome 9702/3 Mature T-cell lymphoma, NOS 9705/3 Angioimmunoblastic T-cell lymphoma 9708/3 Subcutaneous panniculitis-like T-cell lymphoma 9709/3 Cutaneous T-cell lymphoma, NOS (C44._) 9714/3 Anaplastic large cell lymphoma, T cell and Null cell type 9716/3 Hepatosplenic ?? (gamma-delta) cell lymphoma 9717/3 Intestinal T-cell lymphoma 9718/3 Primary cutaneous CD30+ T-cell lymphoproliferative disorder (C44._) 9719/3 NK/T-cell lymphoma, nasal and nasal-type 9727/3 Precursor cell lymphoblastic lymphoma, NOS (see also M-9835/3) 9728/3 Precursor B-cell lymphoblastic lymphoma (see also M-9836/3) 9729/3 Precursor T-cell lymphoblastic lymphoma (see also M-9837/3) 9731/3 Plasmacytoma, NOS 9732/3 Multiple myeloma (C42.1) 9733/3 Plasma cell leukemia (C42.1) 9734/3 Plasmacytoma, extramedullary (not occurring in bone) 9740/1 Mastocytoma, NOS 9740/3 Mast cell sarcoma 9741/3 Malignant mastocytosis 9742/3 Mast cell leukemia (C42.1) 9750/3 Malignant histiocytosis 9751/1 Langerhans cell histiocytosis, NOS 9752/1 Langerhans cell histiocytosis, unifocal 9753/1 Langerhans cell histiocytosis, multifocal 9754/3 Langerhans cell histiocytosis, disseminated 9755/3 Histiocytic sarcoma 9756/3 Langerhans cell sarcoma 9757/3 Interdigitating dendritic cell sarcoma 9758/3 Follicular dendritic cell sarcoma 9760/3 Immunoproliferative disease, NOS 9761/3 Waldenstrom macroglobulinemia (C42.0) (see also M-9671/3) 9762/3 Heavy chain disease, NOS 9764/3 Immunoproliferative small intestinal disease (C17._) 9765/1 Monoclonal gammopathy of undetermined significance 9766/1 Angiocentric immunoproliferative lesion 9767/1 Angioimmunoblastic lymphadenopathy 9768/1 T-gamma lymphoproliferative disease 9769/1 Immunoglobulin deposition disease 9800/3 Leukemia, NOS 9801/3 Acute leukemia, NOS 9805/3 Acute biphenotypic leukemia 9820/3 Lymphoid leukemia, NOS 9823/3 B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma (see also M-9670/3) 9826/3 Burkitt cell leukemia (see also M-9687/3) 9827/3 Adult T-cell leukemia/lymphoma (HTLV-1 positive) Includes all variants 9831/1 T-cell large granular lymphocytic leukemia 9832/3 Prolymphocytic leukemia, NOS 9833/3 Prolymphocytic leukemia, B-cell type 9834/3 Prolymphocytic leukemia, T-cell type 9835/3 Precursor cell lymphoblastic leukemia, NOS (see also M-9727/3) 9836/3 Precursor B-cell lymphoblastic leukemia (see also M-9728/3) 9837/3 Precursor T-cell lymphoblastic leukemia (see also M-9729/3) 9840/3 Acute myeloid leukemia, M6 type 9860/3 Myeloid leukemia, NOS 9861/3 Acute myeloid leukemia, NOS (FAB or WHO type not specified) (see also M-9930/3) 9863/3 Chronic myeloid leukemia, NOS 9866/3 Acute promyelocytic leukemia, t(15;17)(q22;q11-12) 9867/3 Acute myelomonocytic leukemia 9870/3 Acute basophilic leukemia 9871/3 Acute myeloid leukemia with abnormal marrow eosinophils Includes all variants 9872/3 Acute myeloid leukemia, minimal differentiation 9873/3 Acute myeloid leukemia without maturation 9874/3 Acute myeloid leukemia with maturation 9875/3 Chronic myelogenous leukemia, BCR/ABL positive 9876/3 Atypical chronic myeloid leukemia, BCR/ABL negative 9891/3 Acute monocytic leukemia 9895/3 Acute myeloid leukemia with multilineage dysplasia 9896/3 Acute myeloid leukemia, t(8;21)(q22;q22) 9897/3 Acute myeloid leukemia, 11q23 abnormalities 9910/3 Acute megakaryoblastic leukemia 9920/3 Therapy-related acute myeloid leukemia, NOS 9930/3 Myeloid sarcoma (see also M-9861/3) 9931/3 Acute panmyelosis with myelofibrosis (C42.1) 9940/3 Hairy cell leukemia (C42.1) 9945/3 Chronic myelomonocytic leukemia, NOS 9946/3 Juvenile myelomonocytic leukemia 9948/3 Aggressive NK-cell leukemia 9950/3 Polycythemia vera 9960/3 Chronic myeloproliferative disease, NOS 9961/3 Myelosclerosis with myeloid metaplasia 9962/3 Essential thrombocythemia 9963/3 Chronic neutrophilic leukemia 9964/3 Hypereosinophilic syndrome 9970/1 Lymphoproliferative disorder, NOS 9975/1 Myeloproliferative disease, NOS 9980/3 Refractory anemia 9982/3 Refractory anemia with sideroblasts 9983/3 Refractory anemia with excess blasts 9984/3 Refractory anemia with excess blasts in transformation [obs] 9985/3 Refractory cytopenia with multilineage dysplasia 9986/3 Myelodysplastic syndrome with 5q deletion (5q-) syndrome 9987/3 Therapy-related myelodysplastic syndrome, NOS 9989/3 Myelodysplastic syndrome, NOS &commonstagetestistnm7; &commonstagetestis; &commonsummarystage; &commonstagetestis_csv1; Post-orchiectomy Serum Tumor Marker S Value Table Based on SSF 13, 15, 16 Note: This table calculates an intermediary value for S based on the serum tumor markers coded in Site-Specific Factors 13, 15, and 16, as shown in the following table. As of CS Version 2, the S value can be calculated even if SSF10 (LDH) is unknown for both AJCC 6th Edition and AJCC 7th Edition. The S value from this table is used in conjunction with the S value from Serum Marker S Value Table Based on SSF 1, 2, 3. The information is combined based on year of diagnosis: 1) if year of diagnosis is less than 2010, see Combined Serum Marker S Value Table for Year of Diagnosis Less Than 2010; 2) if year of diagnosis is greater then 2009, see Combined Serum Marker S Value Table for Year of Diagnosis Greater Than 2009. CS SSF 13 CS SSF 15 CS SSF 16 S Value 000 000 000 S0 000 000 010 S1 000 000 020 S2 000 000 030 S3 000 000 988 ERROR 000 000 990 S0 000 000 991 S1 000 000 992 S0 000 000 993 S1 000 000 997 S0 000 000 998 S0 000 000 999 S0 000 010 000 S1 000 010 010 S1 000 010 020 S2 000 010 030 S3 000 010 988 ERROR 000 010 990-999 S2 000 020 000 S2 000 020 010 S2 000 020 020 S2 000 020 030 S3 000 020 988 ERROR 000 020 990-999 S2 000 030 000 S3 000 030 010 S3 000 030 020 S3 000 030 030 S3 000 030 988 ERROR 000 030 990-999 S3 000 988 000-999 ERROR 000 990 000 S0 000 990 010 S1 000 990 020 S2 000 990 030 S3 000 990 988 ERROR 000 990 990 S0 000 990 991 S1 000 990 992 S0 000 990 993 S1 000 990 997 S0 000 990 998 S0 000 990 999 S0 000 991 000 S1 000 991 010 S1 000 991 020 S2 000 991 030 S3 000 991 988 ERROR 000 991 990-999 S1 000 992 000 S0 000 992 010 S1 000 992 020 S2 000 992 030 S3 000 992 988 ERROR 000 992 990 S0 000 992 991 S1 000 992 992 S0 000 992 993 S1 000 992 997 S0 000 992 998 S0 000 992 999 S0 000 993 000 S1 000 993 010 S1 000 993 020 S2 000 993 030 S3 000 993 988 ERROR 000 993 990-999 S1 000 997 000 SX 000 997 010 SX 000 997 020 S2 000 997 030 S3 000 997 988 ERROR 000 997 990-999 SX 000 998 000 SX 000 998 010 SX 000 998 020 S2 000 998 030 S3 000 998 988 ERROR 000 998 990-999 SX 000 999 000 SX 000 999 010 SX 000 999 020 S2 000 999 030 S3 000 999 988 ERROR 000 999 990-999 SX 010 000 000 S1 010 000 010 S1 010 000 020 S2 010 000 030 S3 010 000 988 ERROR 010 000 990-999 S1 010 010 000 S1 010 010 010 S1 010 010 020 S2 010 010 030 S3 010 010 988 ERROR 010 010 990-999 S1 010 020 000 S2 010 020 010 S2 010 020 020 S2 010 020 030 S3 010 020 988 ERROR 010 020 990-999 S2 010 030 000 S3 010 030 010 S3 010 030 020 S3 010 030 030 S3 010 030 988 ERROR 010 030 990-999 S3 010 988 000-999 ERROR 010 990 000 S1 010 990 010 S1 010 990 020 S2 010 990 030 S3 010 990 988 ERROR 010 990 990-999 S1 010 991 000 S1 010 991 010 S1 010 991 020 S2 010 991 030 S3 010 991 988 ERROR 010 991 990-999 S1 010 992 000 S1 010 992 010 S1 010 992 020 S2 010 992 030 S3 010 992 988 ERROR 010 992 990-999 S1 010 993 000 S1 010 993 010 S1 010 993 020 S2 010 993 030 S3 010 993 988 ERROR 010 993 990-999 S1 010 997 000 SX 010 997 010 SX 010 997 020 S2 010 997 030 S3 010 997 988 ERROR 010 997 990-999 SX 010 998 000 SX 010 998 010 SX 010 998 020 S2 010 998 030 S3 010 998 988 ERROR 010 998 990-999 SX 010 999 000 SX 010 999 010 SX 010 999 020 S2 010 999 030 S3 010 999 988 ERROR 010 999 990-999 SX 020 000 000 S2 020 000 010 S2 020 000 020 S2 020 000 030 S3 020 000 988 ERROR 020 000 990-999 S2 020 010 000 S2 020 010 010 S2 020 010 020 S2 020 010 030 S3 020 010 988 ERROR 020 010 990-999 S2 020 020 000 S2 020 020 010 S2 020 020 020 S2 020 020 030 S3 020 020 988 ERROR 020 020 990-999 S2 020 030 000 S3 020 030 010 S3 020 030 020 S3 020 030 030 S3 020 030 988 ERROR 020 030 990-999 S3 020 988 000-999 ERROR 020 990 000 S2 020 990 010 S2 020 990 020 S2 020 990 030 S3 020 990 988 ERROR 020 990 990-999 S2 020 991 000 S2 020 991 010 S2 020 991 020 S2 020 991 030 S3 020 991 988 ERROR 020 991 990-999 S2 020 992 000 S2 020 992 010 S2 020 992 020 S2 020 992 030 S3 020 992 988 ERROR 020 992 990-999 S2 020 993 000 S2 020 993 010 S2 020 993 020 S2 020 993 030 S3 020 993 988 ERROR 020 993 990-999 S2 020 997 000 S2 020 997 010 S2 020 997 020 S2 020 997 030 S3 020 997 988 ERROR 020 997 990-999 S2 020 998 000 S2 020 998 010 S2 020 998 020 S2 020 998 030 S3 020 998 988 ERROR 020 998 990-999 S2 020 999 000 S2 020 999 010 S2 020 999 020 S2 020 999 030 S3 020 999 988 ERROR 020 999 990-999 S2 030 000 000 S3 030 000 010 S3 030 000 020 S3 030 000 030 S3 030 000 988 ERROR 030 000 990-999 S3 030 010 000 S3 030 010 010 S3 030 010 020 S3 030 010 030 S3 030 010 988 ERROR 030 010 990-999 S3 030 020 000 S3 030 020 010 S3 030 020 020 S3 030 020 030 S3 030 020 988 ERROR 030 020 990-999 S3 030 030 000 S3 030 030 010 S3 030 030 020 S3 030 030 030 S3 030 030 988 ERROR 030 030 990-999 S3 030 988 000-999 ERROR 030 990 000 S3 030 990 010 S3 030 990 020 S3 030 990 030 S3 030 990 988 ERROR 030 990 990-999 S3 030 991 000 S3 030 991 010 S3 030 991 020 S3 030 991 030 S3 030 991 988 ERROR 030 991 990-999 S3 030 992 000 S3 030 992 010 S3 030 992 020 S3 030 992 030 S3 030 992 988 ERROR 030 992 990-999 S3 030 993 000 S3 030 993 010 S3 030 993 020 S3 030 993 030 S3 030 993 988 ERROR 030 993 990-999 S3 030 997 000 S3 030 997 010 S3 030 997 020 S3 030 997 030 S3 030 997 988 ERROR 030 997 990-999 S3 030 998 000 S3 030 998 010 S3 030 998 020 S3 030 998 030 S3 030 998 988 ERROR 030 998 990-999 S3 030 999 000 S3 030 999 010 S3 030 999 020 S3 030 999 030 S3 030 999 988 ERROR 030 999 990-999 S3 988 000-999 000-999 ERROR 990 000 000 S0 990 000 010 S1 990 000 020 S2 990 000 030 S3 990 000 988 ERROR 990 000 990 S0 990 000 991 S1 990 000 992 S0 990 000 993 S1 990 000 997 S0 990 000 998 S0 990 000 999 S0 990 010 000 S1 990 010 010 S1 990 010 020 S2 990 010 030 S3 990 010 988 ERROR 990 010 990-999 S1 990 020 000 S2 990 020 010 S2 990 020 020 S2 990 020 030 S3 990 020 988 ERROR 990 020 990-999 S2 990 030 000 S3 990 030 010 S3 990 030 020 S3 990 030 030 S3 990 030 988 ERROR 990 030 990-999 S3 990 988 000-999 ERROR 990 990 000 S0 990 990 010 S1 990 990 020 S2 990 990 030 S3 990 990 988 ERROR 990 990 990 S0 990 990 991 S1 990 990 992 S0 990 990 993 S1 990 990 997 S0 990 990 998 S0 990 990 999 S0 990 991 000 S1 990 991 010 S1 990 991 020 S2 990 991 030 S3 990 991 988 ERROR 990 991 990-999 S1 990 992 000 S0 990 992 010 S1 990 992 020 S2 990 992 030 S3 990 992 988 ERROR 990 992 990 S0 990 992 991 S1 990 992 992 S0 990 992 993 S1 990 992 997 S0 990 992 998 S0 990 992 999 S0 990 993 000 S1 990 993 010 S1 990 993 020 S2 990 993 030 S3 990 993 988 ERROR 990 993 990-999 S1 990 997 000 SX 990 997 010 SX 990 997 020 S2 990 997 030 S3 990 997 988 ERROR 990 997 990-999 SX 990 998 000 SX 990 998 010 SX 990 998 020 S2 990 998 030 S3 990 998 988 ERROR 990 998 990-999 SX 990 999 000 SX 990 999 010 SX 990 999 020 S2 990 999 030 S3 990 999 988 ERROR 990 999 990-999 SX 991 000 000 S1 991 000 010 S1 991 000 020 S2 991 000 030 S3 991 000 988 ERROR 991 000 990-999 S1 991 010 000 S1 991 010 010 S1 991 010 020 S2 991 010 030 S3 991 010 988 ERROR 991 010 990-999 S1 991 020 000 S2 991 020 010 S2 991 020 020 S2 991 020 030 S3 991 020 988 ERROR 991 020 990-999 S2 991 030 000 S3 991 030 010 S3 991 030 020 S3 991 030 030 S3 991 030 988 ERROR 991 030 990-999 S3 991 988 000-999 ERROR 991 990 000 S1 991 990 010 S1 991 990 020 S2 991 990 030 S3 991 990 988 ERROR 991 990 990-999 S1 991 991 000 S1 991 991 010 S1 991 991 020 S2 991 991 030 S3 991 991 988 ERROR 991 991 990-999 S1 991 992 000 S1 991 992 010 S1 991 992 020 S2 991 992 030 S3 991 992 988 ERROR 991 992 990-999 S1 991 993 000 S1 991 993 010 S1 991 993 020 S2 991 993 030 S3 991 993 988 ERROR 991 993 990-999 S1 991 997 000 SX 991 997 010 SX 991 997 020 S2 991 997 030 S3 991 997 988 ERROR 991 997 990-999 SX 991 998 000 SX 991 998 010 SX 991 998 020 S2 991 998 030 S3 991 998 988 ERROR 991 998 990-999 SX 991 999 000 SX 991 999 010 SX 991 999 020 S2 991 999 030 S3 991 999 988 ERROR 991 999 990-999 SX 992 000 000 S0 992 000 010 S1 992 000 020 S2 992 000 030 S3 992 000 988 ERROR 992 000 990 S0 992 000 991 S1 992 000 992 S0 992 000 993 S1 992 000 997 S0 992 000 998 S0 992 000 999 S0 992 010 000 S1 992 010 010 S1 992 010 020 S2 992 010 030 S3 992 010 988 ERROR 992 010 990-999 S1 992 020 000 S2 992 020 010 S2 992 020 020 S2 992 020 030 S3 992 020 988 ERROR 992 020 990-999 S2 992 030 000 S3 992 030 010 S3 992 030 020 S3 992 030 030 S3 992 030 988 ERROR 992 030 990-999 S3 992 988 000-999 ERROR 992 990 000 S0 992 990 010 S1 992 990 020 S2 992 990 030 S3 992 990 988 ERROR 992 990 990 S0 992 990 991 S1 992 990 992 S0 992 990 993 S1 992 990 997 S0 992 990 998 S0 992 990 999 S0 992 991 000 S1 992 991 010 S1 992 991 020 S2 992 991 030 S3 992 991 988 ERROR 992 991 990-999 S1 992 992 000 S0 992 992 010 S1 992 992 020 S2 992 992 030 S3 992 992 988 ERROR 992 992 990 S0 992 992 991 S1 992 992 992 S0 992 992 993 S1 992 992 997 S0 992 992 998 S0 992 992 999 S0 992 993 000 S1 992 993 010 S1 992 993 020 S2 992 993 030 S3 992 993 988 ERROR 992 993 990-999 S1 992 997 000 SX 992 997 010 SX 992 997 020 S2 992 997 030 S3 992 997 988 ERROR 992 997 990-999 SX 992 998 000 SX 992 998 010 SX 992 998 020 S2 992 998 030 S3 992 998 988 ERROR 992 998 990-999 SX 992 999 000 SX 992 999 010 SX 992 999 020 S2 992 999 030 S3 992 999 988 ERROR 992 999 990-999 SX 993 000 000 S1 993 000 010 S1 993 000 020 S2 993 000 030 S3 993 000 988 ERROR 993 000 990-999 S1 993 010 000 S1 993 010 010 S1 993 010 020 S2 993 010 030 S3 993 010 988 ERROR 993 010 990-999 S1 993 020 000 S2 993 020 010 S2 993 020 020 S2 993 020 030 S3 993 020 988 ERROR 993 020 990-999 S2 993 030 000 S3 993 030 010 S3 993 030 020 S3 993 030 030 S3 993 030 988 ERROR 993 030 990-999 S3 993 988 000-999 ERROR 993 990 000 S1 993 990 010 S1 993 990 020 S2 993 990 030 S3 993 990 988 ERROR 993 990 990-999 S1 993 991 000 S1 993 991 010 S1 993 991 020 S2 993 991 030 S3 993 991 988 ERROR 993 991 990-999 S1 993 992 000 S1 993 992 010 S1 993 992 020 S2 993 992 030 S3 993 992 988 ERROR 993 992 990-999 S1 993 993 000 S1 993 993 010 S1 993 993 020 S2 993 993 030 S3 993 993 988 ERROR 993 993 990-999 S1 993 997 000 SX 993 997 010 SX 993 997 020 S2 993 997 030 S3 993 997 988 ERROR 993 997 990-999 SX 993 998 000 SX 993 998 010 SX 993 998 020 S2 993 998 030 S3 993 998 988 ERROR 993 998 990-999 SX 993 999 000 SX 993 999 010 SX 993 999 020 S2 993 999 030 S3 993 999 988 ERROR 993 999 990-999 SX 997 000 000 SX 997 000 010 SX 997 000 020 S2 997 000 030 S3 997 000 988 ERROR 997 000 990-999 SX 997 010 000 SX 997 010 010 SX 997 010 020 S2 997 010 030 S3 997 010 988 ERROR 997 010 990-999 SX 997 020 000 S2 997 020 010 S2 997 020 020 S2 997 020 030 S3 997 020 988 ERROR 997 020 990-999 S2 997 030 000 S3 997 030 010 S3 997 030 020 S3 997 030 030 S3 997 030 988 ERROR 997 030 990-999 S3 997 988 000-999 ERROR 997 990 000 SX 997 990 010 SX 997 990 020 S2 997 990 030 S3 997 990 988 ERROR 997 990 990-999 SX 997 991 000 SX 997 991 010 SX 997 991 020 S2 997 991 030 S3 997 991 988 ERROR 997 991 990-999 SX 997 992 000 SX 997 992 010 SX 997 992 020 S2 997 992 030 S3 997 992 988 ERROR 997 992 990-999 SX 997 993 000 SX 997 993 010 SX 997 993 020 S2 997 993 030 S3 997 993 988 ERROR 997 993 990-999 SX 997 997 000 SX 997 997 010 SX 997 997 020 S2 997 997 030 S3 997 997 988 ERROR 997 997 990-999 SX 997 998 000 SX 997 998 010 SX 997 998 020 S2 997 998 030 S3 997 998 988 ERROR 997 998 990-999 SX 997 999 000 SX 997 999 010 SX 997 999 020 S2 997 999 030 S3 997 999 988 ERROR 997 999 990-999 SX 998 000 000 SX 998 000 010 SX 998 000 020 S2 998 000 030 S3 998 000 988 ERROR 998 000 990-999 SX 998 010 000 SX 998 010 010 SX 998 010 020 S2 998 010 030 S3 998 010 988 ERROR 998 010 990-999 SX 998 020 000 S2 998 020 010 S2 998 020 020 S2 998 020 030 S3 998 020 988 ERROR 998 020 990-999 S2 998 030 000 S3 998 030 010 S3 998 030 020 S3 998 030 030 S3 998 030 988 ERROR 998 030 990-999 S3 998 988 000-999 ERROR 998 990 000 SX 998 990 010 SX 998 990 020 S2 998 990 030 S3 998 990 988 ERROR 998 990 990-999 SX 998 991 000 SX 998 991 010 SX 998 991 020 S2 998 991 030 S3 998 991 988 ERROR 998 991 990-999 SX 998 992 000 SX 998 992 010 SX 998 992 020 S2 998 992 030 S3 998 992 988 ERROR 998 992 990-999 SX 998 993 000 SX 998 993 010 SX 998 993 020 S2 998 993 030 S3 998 993 988 ERROR 998 993 990-999 SX 998 997 000 SX 998 997 010 SX 998 997 020 S2 998 997 030 S3 998 997 988 ERROR 998 997 990-999 SX 998 998 000 SX 998 998 010 SX 998 998 020 S2 998 998 030 S3 998 998 988 ERROR 998 998 990-999 SX 998 999 000 SX 998 999 010 SX 998 999 020 S2 998 999 030 S3 998 999 988 ERROR 998 999 990-999 SX 999 000 000 SX 999 000 010 SX 999 000 020 S2 999 000 030 S3 999 000 988 ERROR 999 000 990-999 SX 999 010 000 SX 999 010 010 SX 999 010 020 S2 999 010 030 S3 999 010 988 ERROR 999 010 990-999 SX 999 020 000 S2 999 020 010 S2 999 020 020 S2 999 020 030 S3 999 020 988 ERROR 999 020 990-999 S2 999 030 000 S3 999 030 010 S3 999 030 020 S3 999 030 030 S3 999 030 988 ERROR 999 030 990-999 ERROR 999 988 000-999 ERROR 999 990 000 SX 999 990 010 SX 999 990 020 S2 999 990 030 S3 999 990 988 ERROR 999 990 990-999 SX 999 991 000 SX 999 991 010 SX 999 991 020 S2 999 991 030 S3 999 991 988 ERROR 999 991 990-999 SX 999 992 000 SX 999 992 010 SX 999 992 020 S2 999 992 030 S3 999 992 988 ERROR 999 992 990-999 SX 999 993 000 SX 999 993 010 SX 999 993 020 S2 999 993 030 S3 999 993 988 ERROR 999 993 990-999 SX 999 997 000 SX 999 997 010 SX 999 997 020 S2 999 997 030 S3 999 997 988 ERROR 999 997 990-999 SX 999 998 000 SX 999 998 010 SX 999 998 020 S2 999 998 030 S3 999 998 988 ERROR 999 998 990-999 SX 999 999 000 SX 999 999 010 SX 999 999 020 S2 999 999 030 S3 999 999 988 ERROR 999 999 990-999 SX Serum Tumor Marker S Value Table Based on CS SSF 1, 2, 3 Note: This table calculates an intermediary value for S based on CS Site-Specific Factors 1-3, as shown in the following table. The S value from the serum tumor markers coded in this table is used in conjunction with the S value from Post-orchiectomy Serum Tumor Marker S Value Table Based on CS SSF 13, 15, 16. The information is combined based on year of diagnosis: 1) if year of diagnosis is less than 2010, see Combined Serum Tumor Marker S Value Table for Year of Diagnosis Less Than 2010; 2) if year of diagnosis is greater than 2009, see Combined Serum Tumor Marker S Value Table for Year of Diagnosis Greater Than 2009. CS SSF 1 CS SSF 2 CS SSF 3 S Value 000 000 000 SX 000 000 020 SX 000 000 040 SX 000 000 050 S2 000 000 060 S3 000 000 080 SX 000 000 988 ERROR 000 000 999 SX 000 020 000 SX 000 020 020 SX 000 020 040 SX 000 020 050 S2 000 020 060 S3 000 020 080 SX 000 020 988 ERROR 000 020 999 SX 000 040 000 SX 000 040 020 SX 000 040 040 SX 000 040 050 S2 000 040 060 S3 000 040 080 SX 000 040 988 ERROR 000 040 999 SX 000 050 000 S2 000 050 020 S2 000 050 040 S2 000 050 050 S2 000 050 060 S3 000 050 080 S2 000 050 988 ERROR 000 050 999 S2 000 060 000 S3 000 060 020 S3 000 060 040 S3 000 060 050 S3 000 060 060 S3 000 060 080 S3 000 060 988 ERROR 000 060 999 S3 000 080 000 SX 000 080 020 SX 000 080 040 SX 000 080 050 S2 000 080 060 S3 000 080 080 SX 000 080 988 ERROR 000 080 999 SX 000 988 000 ERROR 000 988 020 ERROR 000 988 040 ERROR 000 988 050 ERROR 000 988 060 ERROR 000 988 080 ERROR 000 988 988 ERROR 000 988 999 ERROR 000 999 000 SX 000 999 020 SX 000 999 040 SX 000 999 050 S2 000 999 060 S3 000 999 080 SX 000 999 988 ERROR 000 999 999 SX 020 000 000 SX 020 000 020 SX 020 000 040 SX 020 000 050 S2 020 000 060 S3 020 000 080 SX 020 000 988 ERROR 020 000 999 SX 020 020 000 S0 020 020 020 S0 020 020 040 S1 020 020 050 S2 020 020 060 S3 020 020 080 S0 020 020 988 ERROR 020 020 999 S0 020 040 000 S0 020 040 020 S1 020 040 040 S1 020 040 050 S2 020 040 060 S3 020 040 080 S0 020 040 988 ERROR 020 040 999 S0 020 050 000 S2 020 050 020 S2 020 050 040 S2 020 050 050 S2 020 050 060 S3 020 050 080 S2 020 050 988 ERROR 020 050 999 S2 020 060 000 S3 020 060 020 S3 020 060 040 S3 020 060 050 S3 020 060 060 S3 020 060 080 S3 020 060 988 ERROR 020 060 999 S3 020 080 000 SX 020 080 020 SX 020 080 040 SX 020 080 050 S2 020 080 060 S3 020 080 080 SX 020 080 988 ERROR 020 080 999 SX 020 988 000 ERROR 020 988 020 ERROR 020 988 040 ERROR 020 988 050 ERROR 020 988 060 ERROR 020 988 080 ERROR 020 988 988 ERROR 020 988 999 ERROR 020 999 000 SX 020 999 020 SX 020 999 040 SX 020 999 050 S2 020 999 060 S3 020 999 080 SX 020 999 988 ERROR 020 999 999 SX 040 000 000 SX 040 000 020 SX 040 000 040 SX 040 000 050 S2 040 000 060 S3 040 000 080 SX 040 000 988 ERROR 040 000 999 SX 040 020 000 S1 040 020 020 S1 040 020 040 S1 040 020 050 S2 040 020 060 S3 040 020 080 S1 040 020 988 ERROR 040 020 999 S1 040 040 000 S1 040 040 020 S1 040 040 040 S1 040 040 050 S2 040 040 060 S3 040 040 080 S1 040 040 988 ERROR 040 040 999 S1 040 050 000 S2 040 050 020 S2 040 050 040 S2 040 050 050 S2 040 050 060 S3 040 050 080 S2 040 050 988 ERROR 040 050 999 S2 040 060 000 S3 040 060 020 S3 040 060 040 S3 040 060 050 S3 040 060 060 S3 040 060 080 S3 040 060 988 ERROR 040 060 999 S3 040 080 000 SX 040 080 020 SX 040 080 040 SX 040 080 050 S2 040 080 060 S3 040 080 080 SX 040 080 988 ERROR 040 080 999 SX 040 988 000 ERROR 040 988 020 ERROR 040 988 040 ERROR 040 988 050 ERROR 040 988 060 ERROR 040 988 080 ERROR 040 988 988 ERROR 040 988 999 ERROR 040 999 000 SX 040 999 020 SX 040 999 040 SX 040 999 050 S2 040 999 060 S3 040 999 080 SX 040 999 988 ERROR 040 999 999 SX 050 000 000 S2 050 000 020 S2 050 000 040 S2 050 000 050 S2 050 000 060 S3 050 000 080 S2 050 000 988 ERROR 050 000 999 S2 050 020 000 S2 050 020 020 S2 050 020 040 S2 050 020 050 S2 050 020 060 S3 050 020 080 S2 050 020 988 ERROR 050 020 999 S2 050 040 000 S2 050 040 020 S2 050 040 040 S2 050 040 050 S2 050 040 060 S3 050 040 080 S2 050 040 988 ERROR 050 040 999 S2 050 050 000 S2 050 050 020 S2 050 050 040 S2 050 050 050 S2 050 050 060 S3 050 050 080 S2 050 050 988 ERROR 050 050 999 S2 050 060 000 S3 050 060 020 S3 050 060 040 S3 050 060 050 S3 050 060 060 S3 050 060 080 S3 050 060 988 ERROR 050 060 999 S3 050 080 000 S2 050 080 020 S2 050 080 040 S2 050 080 050 S2 050 080 060 S3 050 080 080 S2 050 080 988 ERROR 050 080 999 S2 050 988 000 ERROR 050 988 020 ERROR 050 988 040 ERROR 050 988 050 ERROR 050 988 060 ERROR 050 988 080 ERROR 050 988 988 ERROR 050 988 999 ERROR 050 999 000 S2 050 999 020 S2 050 999 040 S2 050 999 050 S2 050 999 060 S3 050 999 080 S2 050 999 988 ERROR 050 999 999 S2 060 000 000 S3 060 000 020 S3 060 000 040 S3 060 000 050 S3 060 000 060 S3 060 000 080 S3 060 000 988 ERROR 060 000 999 S3 060 020 000 S3 060 020 020 S3 060 020 040 S3 060 020 050 S3 060 020 060 S3 060 020 080 S3 060 020 988 ERROR 060 020 999 S3 060 040 000 S3 060 040 020 S3 060 040 040 S3 060 040 050 S3 060 040 060 S3 060 040 080 S3 060 040 988 ERROR 060 040 999 S3 060 050 000 S3 060 050 020 S3 060 050 040 S3 060 050 050 S3 060 050 060 S3 060 050 080 S3 060 050 988 ERROR 060 050 999 S3 060 060 000 S3 060 060 020 S3 060 060 040 S3 060 060 050 S3 060 060 060 S3 060 060 080 S3 060 060 988 ERROR 060 060 999 S3 060 080 000 S3 060 080 020 S3 060 080 040 S3 060 080 050 S3 060 080 060 S3 060 080 080 S3 060 080 988 ERROR 060 080 999 S3 060 988 000 ERROR 060 988 020 ERROR 060 988 040 ERROR 060 988 050 ERROR 060 988 060 ERROR 060 988 080 ERROR 060 988 988 ERROR 060 988 999 ERROR 060 999 000 S3 060 999 020 S3 060 999 040 S3 060 999 050 S3 060 999 060 S3 060 999 080 S3 060 999 988 ERROR 060 999 999 S3 080 000 000 SX 080 000 020 SX 080 000 040 SX 080 000 050 S2 080 000 060 S3 080 000 080 SX 080 000 988 ERROR 080 000 999 SX 080 020 000 SX 080 020 020 SX 080 020 040 SX 080 020 050 S2 080 020 060 S3 080 020 080 SX 080 020 988 ERROR 080 020 999 SX 080 040 000 SX 080 040 020 SX 080 040 040 SX 080 040 050 S2 080 040 060 S3 080 040 080 SX 080 040 988 ERROR 080 040 999 SX 080 050 000 S2 080 050 020 S2 080 050 040 S2 080 050 050 S2 080 050 060 S3 080 050 080 S2 080 050 988 ERROR 080 050 999 S2 080 060 000 S3 080 060 020 S3 080 060 040 S3 080 060 050 S3 080 060 060 S3 080 060 080 S3 080 060 988 ERROR 080 060 999 S3 080 080 000 SX 080 080 020 SX 080 080 040 SX 080 080 050 S2 080 080 060 S3 080 080 080 SX 080 080 988 ERROR 080 080 999 SX 080 988 000 ERROR 080 988 020 ERROR 080 988 040 ERROR 080 988 050 ERROR 080 988 060 ERROR 080 988 080 ERROR 080 988 988 ERROR 080 988 999 ERROR 080 999 000 SX 080 999 020 SX 080 999 040 SX 080 999 050 S2 080 999 060 S3 080 999 080 SX 080 999 988 ERROR 080 999 999 SX 988 000 000 ERROR 988 000 020 ERROR 988 000 040 ERROR 988 000 050 ERROR 988 000 060 ERROR 988 000 080 ERROR 988 000 988 ERROR 988 000 999 ERROR 988 020 000 ERROR 988 020 020 ERROR 988 020 040 ERROR 988 020 050 ERROR 988 020 060 ERROR 988 020 080 ERROR 988 020 988 ERROR 988 020 999 ERROR 988 040 000 ERROR 988 040 020 ERROR 988 040 040 ERROR 988 040 050 ERROR 988 040 060 ERROR 988 040 080 ERROR 988 040 988 ERROR 988 040 999 ERROR 988 050 000 ERROR 988 050 020 ERROR 988 050 040 ERROR 988 050 050 ERROR 988 050 060 ERROR 988 050 080 ERROR 988 050 988 ERROR 988 050 999 ERROR 988 060 000 ERROR 988 060 020 ERROR 988 060 040 ERROR 988 060 050 ERROR 988 060 060 ERROR 988 060 080 ERROR 988 060 988 ERROR 988 060 999 ERROR 988 080 000 ERROR 988 080 020 ERROR 988 080 040 ERROR 988 080 050 ERROR 988 080 060 ERROR 988 080 080 ERROR 988 080 988 ERROR 988 080 999 ERROR 988 988 000 ERROR 988 988 020 ERROR 988 988 040 ERROR 988 988 050 ERROR 988 988 060 ERROR 988 988 080 ERROR 988 988 988 ERROR 988 988 999 ERROR 988 999 000 ERROR 988 999 020 ERROR 988 999 040 ERROR 988 999 050 ERROR 988 999 060 ERROR 988 999 080 ERROR 988 999 988 ERROR 988 999 999 ERROR 999 000 000 SX 999 000 020 SX 999 000 040 SX 999 000 050 S2 999 000 060 S3 999 000 080 SX 999 000 988 ERROR 999 000 999 SX 999 020 000 SX 999 020 020 SX 999 020 040 SX 999 020 050 S2 999 020 060 S3 999 020 080 SX 999 020 988 ERROR 999 020 999 SX 999 040 000 SX 999 040 020 SX 999 040 040 SX 999 040 050 S2 999 040 060 S3 999 040 080 SX 999 040 988 ERROR 999 040 999 SX 999 050 000 S2 999 050 020 S2 999 050 040 S2 999 050 050 S2 999 050 060 S3 999 050 080 S2 999 050 988 ERROR 999 050 999 S2 999 060 000 S3 999 060 020 S3 999 060 040 S3 999 060 050 S3 999 060 060 S3 999 060 080 S3 999 060 988 ERROR 999 060 999 S3 999 080 000 SX 999 080 020 SX 999 080 040 SX 999 080 050 S2 999 080 060 S3 999 080 080 SX 999 080 988 ERROR 999 080 999 SX 999 988 000 ERROR 999 988 020 ERROR 999 988 040 ERROR 999 988 050 ERROR 999 988 060 ERROR 999 988 080 ERROR 999 988 988 ERROR 999 988 999 ERROR 999 999 000 SX 999 999 020 SX 999 999 040 SX 999 999 050 S2 999 999 060 S3 999 999 080 SX 999 999 988 ERROR 999 999 999 SX Combined Serum Tumor Marker S Value Table for Year of Diagnosis Greater Than 2009 Note: If the Year of Diagnosis is greater than 2009 or the case is coded under CSv2 (CS Version Input Original greater than 020000), then the S value will be based on CS Site-Specific Factors 13, 15, and 16. S value based on CS SSF 1-3 S value based on CS SSF 13, 15, 16 =S0 S value based on CS SSF 13, 15, 16 =S1 S value based on CS SSF 13, 15, 16 =S2 S value based on CS SSF 13, 15, 16 =S3 S value based on CS SSF 13, 15, 16 =SX S value based on CS SSF 13, 15, 16 =ERROR S0 S0 S1 S2 S3 SX ERROR S1 S0 S1 S2 S3 SX ERROR S2 S0 S1 S2 S3 SX ERROR S3 S0 S1 S2 S3 SX ERROR SX S0 S1 S2 S3 SX ERROR ERROR S0 S1 S2 S3 SX ERROR Combined Serum Tumor Marker S Value Table for Year of Diagnosis Less Than 2010 Note: If the Year of Diagnosis is less than 2010 and the case is coded under CSv1 (CS Version Input Original less than 020000), then known information in CS Site-Specific Factors 13, 15, and 16 will take precedence. If CS Site-Specific Factors 13, 15, or 16 yield an SX or ERROR from Post-orchiectomy Serum Tumor Marker S Value Table Based on CS SSF 13, 15, 16, then the S value will be based on CS Site-Specific Factors 1, 2, and 3. S value based on CS SSF 1-3 S value based on CS SSF 13, 15, 16 =S0 S value based on CS SSF 13, 15, 16 =S1 S value based on CS SSF 13, 15, 16 =S2 S value based on CS SSF 13, 15, 16 =S3 S value based on CS SSF 13, 15, 16 =SX S value based on CS SSF 13, 15, 16 =ERROR S0 S0 S1 S2 S3 S0 S0 S1 S0 S1 S2 S3 S1 S1 S2 S0 S1 S2 S3 S2 S2 S3 S0 S1 S2 S3 S3 S3 SX S0 S1 S2 S3 SX SX ERROR S0 S1 S2 S3 SX ERROR Extension Orchiectomy LVI AJCC 7 Table Note: For CS Extension codes 160-330 and 460-550 ONLY, the T category for AJCC 7 staging is assigned based on the value of CS Site-Specific Factor 4, Radical Orchiectomy Performed, and Lymph-Vascular Invasion as follows: CS Extension CS SSF 4 Lymph-vascular Invasion T Category 160-330, 460-550 001 0,1,8,9 ERROR 160-330, 460-550 988 0,1,8,9 ERROR 160 000 0 TX 160 000 1 TX 160 000 8-9 TX 160 010 0 T1 160 010 1 T2 160 010 8-9 T1 160 999 0 TX 160 999 1 TX 160 999 8-9 TX 200 000 0 TX 200 000 1 TX 200 000 8-9 TX 200 010 0 T2 200 010 1 T2 200 010 8-9 T2 200 999 0 TX 200 999 1 TX 200 999 8-9 TX 300 000 0 TX 300 000 1 TX 300 000 8-9 TX 300 010 0 T1 300 010 1 T2 300 010 8-9 T1 300 999 0 TX 300 999 1 TX 300 999 8-9 TX 310 000 0 TX 310 000 1 TX 310 000 8-9 TX 310 010 0 TX 310 010 1 T2 310 010 8-9 TX 310 999 0 TX 310 999 1 TX 310 999 8-9 TX 320 000 0 TX 320 000 1 TX 320 000 8-9 TX 320 010 0 T1 320 010 1 T2 320 010 8-9 T1 320 999 0 T1 320 999 1 T2 320 999 8-9 T1 330 000 0 TX 330 000 1 TX 330 000 8-9 TX 330 010 0 T2 330 010 1 T2 330 010 8-9 T2 330 999 0 T2 330 999 1 T2 330 999 8-9 T2 460 000 0 TX 460 000 1 TX 460 000 8-9 TX 460 010 0 T1 460 010 1 T2 460 010 8-9 T1 460 999 0 TX 460 999 1 TX 460 999 8-9 TX 470 000 0 TX 470 000 1 TX 470 000 8-9 TX 470 010 0 T2 470 010 1 T2 470 010 8-9 T2 470 999 0 TX 470 999 1 TX 470 999 8-9 TX 500 000 0 TX 500 000 1 TX 500 000 8-9 TX 500 010 0 T3 500 010 1 T3 500 010 8-9 T3 500 999 0 TX 500 999 1 TX 500 999 8-9 TX 550 000 0 TX 550 000 1 TX 550 000 8-9 TX 550 010 0 T3 550 010 1 T3 550 010 8-9 T3 550 999 0 T3 550 999 1 T3 550 999 8-9 T3 Extension Orchiectomy LVI AJCC 6 Table CSv1 Note: For cases coded under CSv1 (CS Version Input Original less than 020000) and Year of Diagnosis less than 2010 with CS Extension codes 100-550 ONLY, the T category for AJCC 6 staging is assigned based on the value of CS Site-Specific Factor 4, Radical Orchiectomy Performed, and Lymph-Vascular Invasion if coded, as follows: CS Extension CS SSF4 Lymph-vascular Invasion T CATEGORY 100-550 001 0,1,8,9 ERROR 100-550 001 ERROR 100-550 988 0,1,8,9 ERROR 100-550 988 ERROR 100 000 0,8,9 TX 100 000 1 TX 100 000 TX 100 010 0,8,9 T1 100 010 1 T2 100 010 T1 100 999 0,8,9 TX 100 999 1 TX 100 999 TX 150 000 0,8,9 TX 150 000 1 TX 150 000 TX 150 010 0,8,9 T2 150 010 1 T2 150 010 T2 150 999 0,8,9 TX 150 999 1 TX 150 999 TX 160 000 0,8,9 TX 160 000 1 TX 160 000 TX 160 010 0,8,9 T1 160 010 1 T2 160 010 T1 160 999 0,8,9 TX 160 999 1 TX 160 999 TX 200 000 0,8,9 TX 200 000 1 TX 200 000 TX 200 010 0,8,9 T2 200 010 1 T2 200 010 T2 200 999 0,8,9 TX 200 999 1 TX 200 999 TX 300 000 0,8,9 TX 300 000 1 TX 300 000 TX 300 010 0,8,9 T1 300 010 1 T2 300 010 T1 300 999 0,8,9 TX 300 999 1 TX 300 999 TX 310 000 0,8,9 TX 310 000 1 TX 310 000 TX 310 010 0,8,9 TX 310 010 1 T2 310 010 TX 310 999 0,8,9 TX 310 999 1 TX 310 999 TX 320 000 0,8,9 TX 320 000 1 TX 320 000 TX 320 010 0,8,9 T1 320 010 1 T2 320 010 T1 320 999 0,8,9 T1 320 999 1 T2 320 999 T1 330 000 0,8,9 TX 330 000 1 TX 330 000 TX 330 010 0,8,9 T2 330 010 1 T2 330 010 T2 330 999 0,8,9 T2 330 999 1 T2 330 999 T2 400 000 0,8,9 TX 400 000 1 TX 400 000 TX 400 010 0,8,9 T1 400 010 1 T2 400 010 T1 400 999 0,8,9 TX 400 999 1 TX 400 999 TX 450 000 0,8,9 TX 450 000 1 TX 450 000 TX 450 010 0,8,9 T2 450 010 1 T2 450 010 T2 450 999 0,8,9 TX 450 999 1 TX 450 999 TX 460 000 0,8,9 TX 460 000 1 TX 460 000 TX 460 010 0,8,9 T1 460 010 1 T2 460 010 T1 460 999 0,8,9 TX 460 999 1 TX 460 999 TX 470 000 0,8,9 TX 470 000 1 TX 470 000 TX 470 010 0,8,9 T1 470 010 1 T2 470 010 T1 470 999 0,8,9 TX 470 999 1 TX 470 999 TX 500 000 0,8,9 TX 500 000 1 TX 500 000 TX 500 010 0,8,9 T3 500 010 1 T3 500 010 T3 500 999 0,8,9 TX 500 999 1 TX 500 999 TX 550 000 0,8,9 TX 550 000 1 TX 550 000 TX 550 010 0,8,9 T3 550 010 1 T3 550 010 T3 550 999 0,8,9 T3 550 999 1 T3 550 999 T3 Extension Orchiectomy LVI AJCC 6 Table CSv2 Note: For cases coded under CSv2 (CS Version Input Original greater than 020000) or Year of Diagnosis greater than 2009 with CS Extension codes 100-550 ONLY, the T category for AJCC 6 staging is assigned based on the value of CS Site-Specific Factor 4, Radical Orchiectomy Performed, and Lymph-Vascular Invasion as follows: CS Extension CS SSF 4 Lymph-vascular Invasion T Category 100-550 001 0,1,8,9 ERROR 100-550 988 0,1,8,9 ERROR 100 000 0 ERROR 100 000 1 ERROR 100 000 8-9 ERROR 100 010 0 ERROR 100 010 1 ERROR 100 010 8-9 ERROR 100 999 0 ERROR 100 999 1 ERROR 100 999 8-9 ERROR 150 000 0 ERROR 150 000 1 ERROR 150 000 8-9 ERROR 150 010 0 ERROR 150 010 1 ERROR 150 010 8-9 ERROR 150 999 0 ERROR 150 999 1 ERROR 150 999 8-9 ERROR 160 000 0 TX 160 000 1 TX 160 000 8-9 TX 160 010 0 T1 160 010 1 T2 160 010 8-9 T1 160 999 0 TX 160 999 1 TX 160 999 8-9 TX 200 000 0 TX 200 000 1 TX 200 000 8-9 TX 200 010 0 T2 200 010 1 T2 200 010 8-9 T2 200 999 0 TX 200 999 1 TX 200 999 8-9 TX 300 000 0 TX 300 000 1 TX 300 000 8-9 TX 300 010 0 T1 300 010 1 T2 300 010 8-9 T1 300 999 0 TX 300 999 1 TX 300 999 8-9 TX 310 000 0 TX 310 000 1 TX 310 000 8-9 TX 310 010 0 TX 310 010 1 T2 310 010 8-9 TX 310 999 0 TX 310 999 1 TX 310 999 8-9 TX 320 000 0 TX 320 000 1 TX 320 000 8-9 TX 320 010 0 T1 320 010 1 T2 320 010 8-9 T1 320 999 0 T1 320 999 1 T2 320 999 8-9 T1 330 000 0 TX 330 000 1 TX 330 000 8-9 TX 330 010 0 T2 330 010 1 T2 330 010 8-9 T2 330 999 0 T2 330 999 1 T2 330 999 8-9 T2 400 000 0 ERROR 400 000 1 ERROR 400 000 8-9 ERROR 400 010 0 ERROR 400 010 1 ERROR 400 010 8-9 ERROR 400 999 0 ERROR 400 999 1 ERROR 400 999 8-9 ERROR 450 000 0 ERROR 450 000 1 ERROR 450 000 8-9 ERROR 450 010 0 ERROR 450 010 1 ERROR 450 010 8-9 ERROR 450 999 0 ERROR 450 999 1 ERROR 450 999 8-9 ERROR 460 000 0 TX 460 000 1 TX 460 000 8-9 TX 460 010 0 T1 460 010 1 T2 460 010 8-9 T1 460 999 0 TX 460 999 1 TX 460 999 8-9 TX 470 000 0 TX 470 000 1 TX 470 000 8-9 TX 470 010 0 T1 470 010 1 T2 470 010 8-9 T1 470 999 0 TX 470 999 1 TX 470 999 8-9 TX 500 000 0 TX 500 000 1 TX 500 000 8-9 TX 500 010 0 T3 500 010 1 T3 500 010 8-9 T3 500 999 0 TX 500 999 1 TX 500 999 8-9 TX 550 000 0 TX 550 000 1 TX 550 000 8-9 TX 550 010 0 T3 550 010 1 T3 550 010 8-9 T3 550 999 0 T3 550 999 1 T3 550 999 8-9 T3 Lymph Nodes Clinical Eval Table Note: This table is used when CS Lymph Nodes Eval is coded 0 (c), 1(c), 5 (c), or 9 (c) and CS Lymph Nodes is coded 100-500 ONLY. The N category is assigned based on the value of CS Site-Specific Factor 5, Size of Metastasis in Lymph Nodes. CS Lymph Nodes CS SSF 5 000-003 0 3 CS SSF 5 010 10 CS SSF 5 020 20 CS SSF 5 030 30 CS SSF 5 988 988 CS SSF 5 998 998 CS SSF 5 999 999 100 ERROR N1 N2 N3 ERROR ERROR N1 200 ERROR N1 N2 N3 ERROR ERROR N1 300 ERROR N1 N2 N3 ERROR ERROR N1 350 ERROR N1 N2 N3 ERROR ERROR N1 400 ERROR N1 N2 N3 ERROR ERROR N1 500 ERROR N1 N2 N3 ERROR ERROR N1 Lymph Nodes Pathologic Eval Table Note: This table is used when CS Lymph Nodes Eval is coded 2 (p), 3 (p), 6 (yp), or 8 (a) and CS Lymph Nodes is coded 100-500 ONLY. The N category is assigned based on the values of CS Site-Specific Factor 5, Size of Metastasis in Lymph Nodes, and Regional Nodes Positive. Regional Nodes Positive CS SSF 5 000-003 0 3 CS SSF 5 010 10 CS SSF 5 020 20 CS SSF 5 030 30 CS SSF 5 988 988 CS SSF 5 998 998 CS SSF 5 999 999 00-00 ERROR ERROR ERROR ERROR ERROR ERROR ERROR 01-05 ERROR N1 N2 N3 ERROR ERROR N1 06-90 ERROR N2 N2 N3 ERROR ERROR N2 95 ERROR N1 N2 N3 ERROR ERROR N1 97 ERROR N1 N2 N3 ERROR ERROR N1 98 ERROR ERROR ERROR ERROR ERROR ERROR ERROR 99 ERROR ERROR ERROR ERROR ERROR ERROR ERROR Lymph Nodes Positive Eval Blank Table Note: This table is used when CS Lymph Nodes Eval is not coded and CS Lymph Nodes is coded 100-500 ONLY. The N category is assigned based on the values of CS Site-Specific Factor 5, Size of Metastasis in Lymph Nodes, and Regional Nodes Positive. The N category is based on the clinical definition except when Regional Nodes Positive is greater than 05; then the N category is based on the pathologic definition. Regional Nodes Positive CS SSF 5 000-003 0 3 CS SSF 5 010 10 CS SSF 5 020 20 CS SSF 5 030 30 CS SSF 5 988 988 CS SSF 5 998 998 CS SSF 5 999 999 00-00 ERROR N1 N2 N3 ERROR ERROR N1 01-05 ERROR N1 N2 N3 ERROR ERROR N1 06-90 ERROR N2 N2 N3 ERROR ERROR N2 95 ERROR N1 N2 N3 ERROR ERROR N1 97 ERROR N1 N2 N3 ERROR ERROR N1 98 ERROR N1 N2 N3 ERROR ERROR N1 99 ERROR N1 N2 N3 ERROR ERROR N1